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FUNCTIONAL INTERACTIONS BETWEEN HELICOBACTER-
ACTIVATED B (HACT-B) CELLS AND CD4
+
 T CELLS 
SUMMARY 
Helicobacter pylori is a spiral-shaped, gram-negative bacterium that infects the 
gastric mucosa of more than half of the world‟s population. The infection initially 
occurs in childhood, becomes persistent and the chronic infection leads to gastric 
inflammation. A major virulence factor of H. pylori is the cytotoxin-associated gene 
A (CagA) protein and this CagA protein interacts with several intracellular 
components of signal transduction and activates some crucial signaling pathways. 
Helicobacter has developed a variety of mechanisms to persist in the gastric mucosa. 
Gastric epithelial cells (GECs) are primary target for H. pylori infection, therefore 
they are the first point of contact for H. pylori and activate an innate immune 
response through TLRs. Rather than being a strong TLR4 ligand, H. pylori LPS is 
thought to activate TLR2 on gastric epithelial cells. Animal and cell culture 
experiments suggested that ligands in Helicobacter species can bind to TLR2 and 
activate NF-κB in epithelial cells. In mouse studies, Helicobacter felis (H. felis) is 
mainly used because it is more immunogenic than H.pylori in mice. 
B cells and their cytokines have important roles in Helicobacter infections by 
balancing between the infection and T cell driven gastric immunopathology. The 
ability of B cells to interact with pathogenic T cells and to produce anti-inflammatory 
cytokines such as IL-10 is crucial to dampen harmful immune responses. It has been 
found that B-cells exposed to Helicobacter sonicate produced large amounts of the 
regulatory cytokine IL-10. Using mouse models of Helicobacter-induced gastric 
premalignant pathology, it is shown that IL-10 secretion by purified B cells 
absolutely required MyD88 signaling and TLR-2.  
The TLR-2- dependent Helicobacter activation of B cells differentiates them into IL-
10 and TGF-β producing regulatory B cells. Both IL-10 and TGF-β have crucial 
effects on T cell differentiation. When co-cultured with Helicobacter-activated B 
cells, naive CD4
+
 T-cells are shown to produce IL-10 and differentiate into T 
regulatory 1 (Tr1)-like cells. In addition to that, it is suggested that Breg cells 
contribute to regulatory T-cell induction by producing TGF-β. At the same time, 
studies have shown convincingly that TGF-β is required for Th17 differentiation in 
vitro and in vivo. 
In previous studies in our laboratory, Helicobacter-activated total B cells were 
separated into two subgroups: IL-10
+
 B cells and IL-10
-
 B cells. The experimental 
results showed that Helicobacter-activated IL-10
+
 B cells are the source of the IL-10 
production while Helicobacter-activated IL-10
-
B cells are mostly TGF-β positive. 
However, it was not clear if the Helicobacter-acitvated-IL-10
+
 B cells or the 
Helicobacter-activated-IL-10
-
 B were specifically causing the Tr1 differentiation. 
Taking account that Bregs are known for producing IL-10 and TGF-β which are key 
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cytokines in T cell differentiation, the interaction between Helicobacter-activated B 
cell subgroups and CD4
+
 T cell differentiation was investigated. 
By magnetic isolation techniques, CD19
+
B cells and CD4
+
T cells were isolated from 
the spleens of C57BL/6 mice with high purities (with an average of 90% and 93%, 
respectively). Following the B cell isolation, cells were treated with Helicobacter 
felis sonicate (10 µg/ml) for 24 hours. For the last 5 hours of incubation, to induce an 
optimal IL-10 production and secretion, PMA (50 ng/ml) and ionomycin (500 ng/ml) 
were added. After the in vitro stimulation of B cells, IL-10 producing B cells were 
labeled and the IL-10
+
B and IL-10
-
B cells were separated. To observe the interaction 
between the Helicobacter-activated-B cell subgroups and CD4
+
 T cells, isolated 
CD4
+ 
T cells were put on co-culture in 1:1 ratio with the Helicobacter-activated-IL-
10
+
 B cells and Helicobacter-activated-IL-10
-
 B cells, for 24 hours. The cell surface 
markers and intracellular cytokine productions were examined by flow cytometry. 
While the supernatants of the co-culture groups were subjected to ELISA tests, the 
cell pellets were used for gene expression analyses. 
The intracellular staining of IL-10 of T cells co-cultured with Helicobacter-activated 
B cell subgroups showed that about 15% of T cells co-cultured with HACT-IL-10
+
 B 
cells produced IL-10 while almost 20% of the T cell population was IL-10 positive 
when T cells were co-cultured with HACT-IL-10
-
 B cells. In addition, according to IL-
10 ELISA results, CD4
+
T cells co-cultured with IL-10
+
B cells and IL-10
-
B cells 
secreted twice IL-10 when compared to only T cells. For IL-10
+
B cell and T cell co-
culture, a part of secreted IL-10 came from B cells while most of the IL
-
10 secreted 
from IL-10
-
B cell and T cell co-culture originated is suggested to be from T cells.  
CD25 has been used as a marker to identify activated T cells as well as  some 
regulatory T cell subsets in mice; while CD62L has been known to rapidly shed from 
lymphocytes upon cellular activation. Both CD25 and CD62L levels in co-culture 
groups showed significant differences compared to T only groups. Furthermore, the 
differences in T cell CD25 and CD62L levels together might indicate that T cells co-
cultured with Helicobacter-activated IL-10
-
B cells are more activated/differentiated 
compared to the T cells interacting with IL-10
+
B cells. 
In literature, it has been shown that B cells which were activated by Helicobacter 
induce IL-10–producing CD4+CD25+ Tr1–like cells in vitro. In addition, it has been 
identified that the co-expression of CD49b and LAG-3 distinguishes Tr1 cells from 
Th1, Th2 and Th17 cells. Flow cytometry results of CD4-CD49b-LAG3 stainings 
showed that  almost 20% of  T cells co-cultured with IL-10
+
B cells express CD4-
CD49b-LAG3 surface markers while only around 10% of CD4
+
 T cells co-cultured 
with IL-10
-
B cells express CD49b and LAG3 together.  
CD4
+
 T cells obtain distinct functional properties in response to signals sent by 
commensal and pathogenic microbe-activated cells of the innate immune system. 
Th17 cells secrete interleukin-17 (IL-17), IL-17F, and IL-22 and have significant 
roles in protecting the host from bacterial and fungal infections, particularly at 
mucosal surfaces. Data of four independent experiments showed that the 
approximately 15%  of CD4
+
 T cells co-cultured with IL10
-
B cells turned into IL17 
producing CD4
+
 T cells while surprisingly about 8% of T cells also produced IL-17 
when co-cultured with IL10
+
B cells. IL-17 ELISA results were parallel with the IL-
17 intracellular cytokine staining analyses. Ror gamma T  and IL-17 relative gene 
expression levels in co-culture groups showed similar results with flow cytometry 
and ELISA results. 
xxiii 
 
Main research focus of this study was to investigate the interaction between HACT-B 
cell subgroups and CD4
+ 
T cells and understand the effects of these B cell subgroups 
on T cell differentiation ex vivo. The results revealed that both Helicobacter-
activated IL-10
+
B and IL-10
-
B cells induce IL-10 production from CD4
+
T cells and 
it might suggest that T cells differentiate into Tr1-like cells in both co-culture 
conditions. Although the CD25 and CD62L expression on T cell surfaces show 
significantly higher activation/differentiation in Helicobacter-activated IL-10
-
B and 
T cell co-cultures, regulatory type indicator CD4-CD49b-LAG3 surface marker co-
expressions were higher on T cells in the Helicobacter-activated IL-10
+
B and T cell 
co-cultures. Furthermore, intracellular IL-17A  levels and relative gene expression 
experiments of IL-17A  and RorgammaT showed significantly higher results  in IL-
10
- 
B and T cell co-culture groups, as expected. On the other hand, interestingly IL-
17 production was also observed in T cells co-cultured with IL-10
- 
B cells. The 
reason behind the IL-17 and RorgammaT expressions in IL-10
+ 
B–T cell co-culture 
groups was suggested to be the IL-6 and TGF- β produced by IL-10 negative B cell 
population in the IL-10 positive co-culture group. This study has contributed to the 
literature through providing a first step to show the ex vivo interactions of 
Helicobacter-activated B cells subgroups, IL10
+
 HACT B cells and IL-10
- 
HACT B 
cells, with CD4
+ 
T cells. 
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HELICOBACTER-AKTİVE (HAKT-B) HÜCRELERİNİN CD4
+
 T HÜCRELERİ 
İLE FONKSİYONEL ETKİLEŞİMLERİ 
ÖZET 
Helicobacter pylori, dünya popülasyonunun yarısından fazlasını enfekte etmiĢ 
bulunan, gram-negatif, spiral yapıda, mikroaerofilik bir bakteri olmakla beraber 
gastritten mide kanserine kadar uzanan gastrik patolojilerin temel risk faktörü olarak 
tanımlanmıĢtır. Enfeksiyonlar genelde çocukluk çağlarında meydana geldiğinden, 
dünya genelinde enfekte olan kiĢi sayısı oldukça fazla olmasına karĢın, enfekte 
bireylerin büyük bir kısmı herhangi bir semptom göstermezken, popülasyonun 
yalnızca % 20‟sinde gastrite, gastrik ve duodenal ülserlere ve ilerleyen zamanda 
gastrik adenokarsinoma sebep olmaktadır. Helicobacter‟in etkisini incelemek için 
fare modelleri kullanılarak yapılan çalıĢmalarda, Helicobacter pylori‟ye yakınlığıyla 
bilinen ve CagA virülans faktörü bulundurmamasına rağmen enfeksiyonlarda 
pylori‟ye oldukça benzer sonuçlar veren Helicobacter felis kullanılmaktadır. 
Helicobacter felis de gram negatif, helikal Ģekilli ve mikroaerofilik bir bakteridir. 
Ġmmün sistem hücreleri, mikroçevrelerinde bulunan patojenleri tanımak için hücre 
yüzeylerinde bazı reseptörlere ihtiyaç duymaktadır.  
Toll benzeri reseptörler (Toll-like receptors -TLR), birçok patojenin varlığında sinyal 
üreterek doğal immün cevabın oluĢmasını sağlayan bir grup tip 1 transmembran 
proteinidir. Hayvan ve hücre kültürü deneyleri, H.pylori kaynaklı ligandların B 
hücrelerinde aktivasyonu TLR2 yolu ile yaptığı ortaya konmuĢtur. Antijen sunucu 
hücreler (APC- antiger presenting cell) olan B hücrelerinin ve T hücrelerinin IL-10 
üreten regülatör alt tipleri olduğu bilinmektedir. Güncel araĢtırmalar, Helicobacter 
felis (H.felis) enfeksiyonlu fare modellerinde TLR-2 yoluyla  IL-10 üreten B 
hücrelerinin immün cevabı baskılayıcı ve düzenleyici rolü olduğunu ortaya 
koymuĢtur.  
Yardımcı T (Th) hücrelerinin bir alt kümesi olan Th17 (T helper 17) hücrelerinin ve 
salgıladıkları interlökin 17 (IL-17) sitokininin, Helicobacter gibi bakterilerin 
temizlenmesinde kritik rolü vardır. Th17 dönüĢümü için transforme edici büyüme 
faktörü-β (TGF-β), IL-21, IL-6 gibi sitokinleri etkili olduğu önerilmiĢtir. Th17 için 
oldukça önemli bir transkripsiyon faktörü olan RORγt, IL-17 gen transkripsiyonunu 
tetikler. Fakat kronik gastrik enflamasyon sırasında, üretilen IL-17 seviyesinin 
enfeksiyonu temizlemeye yeterli olmadığı görülmektedir. Buna sebep olarak, 
bakterinin kendi devamlılığını sağlamak amacıyla diğer immün hücreleri aracılığıyla, 
T hücrelerini, Th17 etkisini bastıran ve düzenleyici etkiler gösteren regülatör T 
hücrelerine dönüĢtürdüğü düĢünülmektedir. Doğal regülatör T hücreleri olarak 
bilinen nTreg‟ler (CD4+CD25+FoxP3+) timustaki geliĢim sırasında fonksiyon 
kazanırken, indüklenebilir Treg (iTreg) periferde naif CD4+ T hücrelerin 
farklılaĢması sırasında geliĢir. Fare ve insan Tr1 hücreleri ile yapılan çalıĢmalarda, 
hücre yüzeyinde bulunan CD49b ve lenfosit aktivasyon geni 3 (LAG-3)‟ün her 
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ikisinin de aynı anda yüzeyde eksprese edilmesinin IL-10 salgılayan Tr1 hücrelerini 
Th1, Th2 ve Th17 hücrelerinden ayırdığı ortaya atılmıĢtır.  
Helicobacter felis ile yapılan fare enfeksiyon modeli çalıĢmalarında, Helicobacter ile 
aktive edilen B hücrelerinin in vivo ve in vitro koĢullarda T hücrelerini IL-10 üreten 
CD4
+
CD25
+ 
Tr1-benzeri hücrelere dönüĢtürdükleri gösterilmiĢtir. Bu çalıĢmalarda, B 
hücreleri tarafından indüklenen Tr1 hücrelerinin in vitro koĢullarda baskılayıcı 
aktivite gösterdiği ve in vivo koĢullarda Helicobacter‟e bağlı immünopatolojiyi 
baskıladığı ortaya konmuĢtur. Ayrıca, daha önce laboratuvarımızda yapılan 
çalıĢmalarda, Helicobacter-aktive B hücrelerinin TGF-β ürettiği gösterilmiĢtir. 
Ancak Helicobacter-aktive B hücrelerinden, IL-10 üreten ya da üretmeyen 
gruplardan hangisinin T hücrelerini IL-10 üreten Tr1-benzeri hücrelere 
dönüĢtürmede rolü olduğu bilinmemektedir. Bu nedenle, bu çalıĢmada Helicobacter-
aktive B hücre alt gruplarının CD4+ T hücre farklılaĢmaları (Tr1 veya Th17) üzerine 
olan etkilerinin incelenmesi amaçlanmıĢtır. 
Manyetik izolasyon teknikleri kullanılarak, CD19+ B hücreleri ve CD4+ T hücreleri, 
C57BL/6 farelerin dalaklarından %90‟dan yüksek saflıklarla izole edilmiĢtir. B hücre 
izolasyonunu takiben hücreler Helicobacter felis sonikatı ile 24 saat muamele 
edilmiĢtir. Optimum bir IL-10 üretimi için inkübasyonun son 5 saatinde PMA ve 
iyonomisin hücrelere eklenmiĢtir. B hücrelerinin Helicobacter felis sonikatı ile in 
vivo tetiklenmesinin ardından IL-10 üreten hücreler manyetik olarak etiketlenerek bu 
sitokini üretmeyen IL-10 negatif B hücrelerinden manyetik ayrım yöntemi ile 
ayrılmıĢtır. Helicobacter-aktive B hücre alt grupları olan IL-10+ HAKT-B hücreleri ve 
IL-10
-
 HAKT-B hücrelerinin CD4
+
 T hücreleri üzerindeki etkilerinin incelenmesi için 
bu hücreler 24 saat boyunca ko-kültüre konmuĢtur. Helicobacter-aktive B hücre alt 
gruplarının CD4+ T hücre farklılaĢmaları (Tr1 veya Th17) üzerine olan etkileri RNA 
(kantitatif PZR) ve protein düzeyinde (ELIZA, hücre içi akan hücre ölçer analizi) 
incelenmiĢtir.  
Hücre içinde özgün antikorlar ile boyanan IL-10 analiz sonuçları göstermektedir ki, 
hem IL-10
+
 HAKT-B hücreleri hem de IL-10
-
 HAKT-B hücreleri CD4
+
 T hücrelerinde 
IL-10 üretimine yol açarak bu hücrelerin Tr1-benzeri hücrelere dönüĢmesinde rol 
almaktadır. 24 saat ko-kültür boyunca hücre dıĢına salgılanan IL-10‟un ölçümünde 
kullanılan IL-10 ELISA sonuçları da akan hücre ölçer sonuçlarını desteklemektedir. 
Aktive olmuĢ ve regülatör T hücrelerinin yüzeyinde bulunan CD25‟in ve T 
hücrelerinde aktive olduktan sonra ekspresyonu azalan CD62L‟nin özgün 
antikorlarla etiketlenerek akan hücre ölçerde analizlerinin sonucunda IL-10- HAKT-B 
hücreleri ile ko-kültürde tutulan CD4+ T hücrelerinin daha fazla aktive olduğu ya da 
farklılaĢtığı önerilmektedir. Literatürde regülatör T hücre belirteci olarak kullanılan 
CD49b ve LAG-3 yüzey belirteçlerinin birlikte eksprese edilmesinin incelenmesi 
sonucunda, IL-10
+
 HAKT-B hücreleri ile birlikte tutulan T hücrelerinin yaklaĢık 
%20‟si bu belirteçleri bir arada gösterirken, IL-10- HAKT-B hücreleri ile ko-kültürde 
tutulan T hücrelerinin ancak %10‟u bu belirteci aynı anda eksprese etmektedir. 
Ġkincil olarak, Helicobacter-aktive B hücreleri ile etkileĢime giren T hücrelerindeki 
IL-17 üretimi incelenmiĢtir. Hücre dıĢına salınımı engellenen IL-17 sitokininin hücre 
içi boyama sonuçlarına göre IL-10- HAKT-B hücreleri ile ko-kültürde tutulan T 
hücrelerinin %15‟i IL-17 üretimi gerçekleĢtirirken, IL-10+ HAKT-B hücreleri T 
hücrelerinin yaklaĢık %8‟ini IL-17 üretmesi için tetiklemiĢtir. IL-17 ELISA 
sonuçlarının yanı sıra IL-17 üretiminde önemli bir transkripsiyon faktörü olan Ror 
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gamma T ve IL-17‟nin gen düzeyinde kantitatif PZR ile incelenmesinin sonuçları da 
akan hücre ölçer sonuçları ile paralellik göstermiĢtir. 
Bütün bu sonuçlar bir araya getirildiğinde, Helicobacter-aktive B hücre alt grupları 
her ikisinin de CD4
+ T hücrelerinin IL-10 ürettiğini göstermiĢtir. Bu sonuçlara 
dayanarak, IL-10
+
 HAKT-B ve IL-10
-
 HAKT-B hücrelerinin T hücrelerinin Tr-1 benzeri 
hücrelere dönüĢmesinde etkisinin olduğu ortaya atılmıĢtır. Regülatör T hücre 
belirteci olarak kabul edilen CD49b-LAG3 yüzey belirteçlerinin ko-ekspresyonunun, 
IL-10
+
 HAKT-B hücreleri ile birlikte tutulan CD4
+
 T hücrelerinde daha yüksek olması 
bu hücrelerin regülatör profile daha yakın olduğunu önerirken, CD25 ve CD62L 
sonuçları IL-10- HAKT-B hücreleri ile ko-kültürde tutulan T hücrelerinin daha aktive 
olmuĢ/farklılaĢmıĢ olduğunu desteklemektedir. Fakat bu aktivasyonun ya da 
farklılaĢmanın özgün olup olmadığı belli değildir. Bununla beraber, IL-17‟nin hem 
protein düzeyinde hem de gen düzeyindeki incelemeleri CD4+ T hücrelerini Th17 
benzeri hücrelere farklılaĢmasında IL-10- HAKT-B hücrelerinin IL-10
+
 HAKT-B 
hücrelerine kıyasla daha fazla rolü olduğunu göstermiĢtir. Th17 farklılaĢmasında 
TGF-betanın önemi göz önünde bulundurulduğunda, bu sonuçlar, daha önceden IL-
10
-
 HAKT-B hücrelerinin, IL-10 pozitif gruba göre daha fazla TGF-beta ve IL-6 
ürettiğinin gösterilmesi ile tutarlıdır. Bu çalıĢma literatüre, Helicobacter-aktive B 
hücre alt grupları, IL10+ HAKT B ve IL10
-
 HAKT B hücrelerinin, CD4
+
 T hücreleri ile 
ex vivo iliĢkisini gösteren ilk çalıĢma olarak katkıda bulunmaktadır. 
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1.  INTRODUCTION 
1.1 Helicobacter Species 
1.1.1 Helicobacter pylori (H. pylori) 
Helicobacter pylori is a spiral-shaped, gram-negative bacterium that infects the 
gastric mucosa of more than half of the world‟s population (Figure 1.1). The 
infection initially occurs in childhood, becomes persistent and the chronic 
infection leads to gastric inflammation (Marshall, 1994). It is the major cause of 
gastritis, gastric and duodenal ulcers, as well as gastric adenocarcinoma 
(Parsonnet, 1991; Coghlan, 1987). 
A major virulence factor of H. pylori is the cytotoxin-associated gene A (CagA) 
protein and it has been shown that patients infected with cagA
+ 
strains have higher 
levels of inflammatory responses and they have a higher risk of developing peptic 
ulcer or gastric cancer (Uemura, 2001; Blaser, 1996). CagA is encoded by the 
cagA gene within the cag pathogenicity island, a 40-kb chromosomal region that 
encodes for a type IV secretion system (T4SS). This CagA protein interacts with 
several intracellular components of signal transduction and activates NF-kB, 
MAPK, STAT3, and PI3K/Akt pathways (Churin, 2013; Lee, 2012). Previous 
reports have highlighted the fact that H. pylori activates STAT3 to modulate host 
immune responses (Lee et al., 2012). 
Gastric epithelial cells (GECs) are the primary target for H. pylori infection. After 
H. pylori adheres to GECs, the CagA protein is translocated into their cytosol via a 
T4SS (Asahi, 2000). Once inside GECs, CagA becomes phosphorylated and 
elicits multiple cell responses, including disruption of epithelial tight junctions, 
cytoskeleton rearrangement, changes in cellular adhesion properties and polarity, 
as well as secretion of proinflammatory mediators (Bourzac, 2005; Hatakeyama, 
2004). Despite the marked inflammatory response within the H. pylori–infected 
gastric mucosa, the host immune response is unable to clear H. pylori, resulting in 
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persistent infection and development of chronic gastric inflammation (Beswick, 
2005; Müller, 2011). 
1.1.2 Helicobacter felis (H. felis) 
Helicobacter felis, which does not express CagA or VacA, causes chronic 
infection and inflammation in a well-characterized mouse model. Being closely 
related to Helicobacter pylori, Helicobacter felis is also a gram negative, helical 
shaped, microaerophilic bacterium that colonizes in the stomach of cats and mice 
(Figure 1.1). Lee and his colleagues first isolated H. felis from stomach of cats in 
1988 (Lee, 1988). Even though, H.felis does not have CagA or VacA virulence 
factors, the Helicobacter felis infection and prognosis of disease in mouse models 
have a striking resemblance to Helicobacter pylori infection in humans 
(Mohammadi, 1996; Mc Cracken, 2005). 
 
Figure 1.1: Helicobacter pylori and Helicobacter felis. (A) Scanning electron micrograph 
of Helicobacter felis isolated from the gastric mucosa of a cat. The characteristic spiral 
morphology and periplasmic fibers are shown. (B) Scanning electron micrograph of 
H.pylori from human gastric epithelium. The gently curved morphology, multiple polar 
flagella, and absence of periplasmic fibers are shown. Micrographs courtesy of Lucinda 
Thompson, presently at Stanford University, USA. 
1.2 B Cells 
In 1965, Max Cooper and Robert Good  published a landmark study in Nature that 
led to the birth of the B cell field (Cooper, 1965). Working with chickens, they 
showed that cells that develop in the bursa of Fabricius (B cells) are responsible 
for antibody production, whereas those cells that develop in the thymus (T cells) 
A B 
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are necessary for delayed-type hypersensitivity responses. B lymphocytes are 
essential components of the humoral immune response. Produced in the bone 
marrow, B cells migrate to the spleen and other secondary lymphoid tissues where 
they mature and differentiate into immunocompetent B cells (Figure 1.2).   
 
Figure 1.2:  B cell development. Stages of B-cell maturation are indicated by their 
anatomical site and the expression of cell-surface markers. 
The initial part of B cell development occurs in the bone marrow and this antigen-
independent step generates mature and immunocompetent B cells that bind to a 
unique antigen. The antigen-independent maturation into immunocompetent 
naïve, mature follicular B cells is completed in the bone marrow and spleen. 
Following maturation in the bone marrow and spleen, immunocompetent B cells 
remain in peripheral tissues until they encounter an antigen. The first activation 
signal occurs upon antigen binding to B cell receptors (BCRs). Upon binding to 
the BCR, the antigen is internalized by receptor-mediated endocytosis, digested, 
and complexed with Major histocompatibility complex class II  (MHC II) 
molecules on the B cell surface.  
The second activation signal occurs via either a thymus-dependent or a thymus-
independent mechanism. The thymus-dependent activation requires the interaction 
of B cells with T helper cells. B cells acting as antigen-presenting cells (APCs) to 
T cells, T cell receptors (TCR) on T helper cells bind to the antigen-complexed 
MHC class II molecule on the B cell surface resulting in T cell activation. The 
second activation signal to the B cells is then provided by these activated T cells 
via CD40-CD40L (CD154) interaction and cytokine secretion (Figure 1.3) (Pierce, 
2002).  
4 
 
Alternatively, there are a few thymus-independent activation types where antigens 
can directly provide the second B cell activation signal. These antigens include 
components of some bacterial cell wall components (e.g., lipopolysaccharide) or 
antigens containing highly repetitious molecules (e.g., bacterial flagellin). T-cell 
independent type I antigens (e.g. LPS, CpG) bind Toll-like receptors (TLR) to 
activate B cells. On the other hand, T-cell independent type II antigens (e.g. 
repetitive sequences) are cross - linked to BCR to activate B cells. Primary B cell 
response and memory B cell response occur after type II antigens.  B-1 and 
marginal zone (MZ) B cells are responding to these T-cell independent antigens 
and produces IgM and/or IgG3 antibodies (Moresco, 2010). 
 
Figure 1.3: T cell-dependent B cell activation. B cells will capture antigen through their 
B cell receptor and display peptides on their MHC II molecules. This attracts T cells 
specific for the peptide. These T cells can then provide costimulatory molecules such as 
CD40L on a T cell that binds to CD40 on the B cell that help the B cell to mature 
(adapted from Biolegend). 
As an important B cell surface marker, CD19 is a 95 kD type I transmembrane 
glycoprotein also known as B4. It is expressed on B-cells from pro-B to blastoid B 
cells, absent on plasma cells (Kumar, 2010). CD19 is involved in B cell 
development, activation, and differentiation.  
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1.2.1 Plasma and memory B cells 
Upon activation, B cells proliferate and form germinal centers where they 
differentiate into memory B cells or plasma (effector) B cells. Following 
differentiation into plasma cells, additional signals initiate plasma cell antibody 
class switching and regulate antibody secretion. The primary function of plasma 
cells is the secretion of B cell clone-specific antibodies. Each plasma cell secretes 
antibodies containing a clonally-unique antigen-binding region joined to a 
constant immunoglobulin (Ig) isotype-defining region. 
The success of humoral memory depends on at least two layers of defense. If the 
antibody concentration at the site is sufficiently high, the pre-existing protective 
antibodies secreted by long-lived plasma cells function as a first line of defense. If 
this constitutive memory is not sufficient, the pathogen-experienced memory B 
cells are rapidly reactivated to produce antibodies by reactive humoral memory. 
Compared with the primary antibody response, the reactive humoral memory 
response is typically faster, of greater magnitude and consists of antibodies of 
switched isotypes and higher affinity (Ahmed&Gray, 1996).  
1.2.2 Regulatory B cells 
The immune response has evolved to protect the host from a wide range of 
potentially pathogenic microorganisms, but parallel mechanisms to control over 
extreme immune responses to limit host damage. Because of their capability to 
produce antibodies, including autoantibodies, B cells are generally considered to 
be positive regulators of the immune response. As antigen-presenting cells, B cells 
facilitate optimal CD4
+
 T cell activation and exert other modulatory functions in 
immune responses. On the other hand, certain B cells can also negatively regulate 
the immune response by producing regulatory cytokines and directly interacting 
with pathogenic T cells via cell-to-cell contact. The hypothesis that suppressor or 
regulatory B (Bregs) cells control the immune system was proposed in the 1970s 
and maintains that the suppressive function of B cells was mainly restricted to 
their ability to produce „inhibitory‟ antibodies (Morris&Moller, 1968). Bhan and 
Mizoguchi were the first to introduce the term „regulatory B cells‟ (Mizoguchi et 
al.,1997). The regulatory function of Breg cells has been demonstrated in mouse 
models of inflammation, cancer, transplantation, and particularly in autoimmunity 
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(Yang et al., 2013). Regulatory B cells have immunosuppressive roles that support 
immunological tolerance. Janeway and colleagues first observed that transgenic 
mice lacking B cells suffered an unusually severe and chronic form of 
experimental autoimmune encephalomyelitis (EAE), indicating that B cells have 
regulatory properties in a mouse model of EAE (Wolf et al.,1996). After a while, 
it was found that B cells affected this autoimmune disease by regulating 
interleukin-10 (IL-10) (Fillatreau et al., 2002). By producing IL-10, IL-35, and 
transforming growth factor β (TGF-β), Breg cells suppress immunopathology by 
prohibiting the expansion of pathogenic T cells and other pro-inflammatory 
lymphocytes (Rosser, 2015). In several animal models, Breg stimulation is 
effective in correcting a variety of autoimmune disorders, most notably those 
initiated in the mucous membranes (Berthelot, 2013). Nonetheless, these cells can 
be phenotypically difficult to identify, as they bear many common  markers found 
on other B cell types. The most well studied Bregs may be the B10 with known 
surface markers CD19, CD1d, CD24, CD5, CD21, CD23 and Transitional 2 
Marginal Zone Precursor (T2-MZP) (surface markers CD19, CD1d, CD24 and 
CD93) population (Mauri, 2010). 
1.2.3 Activation and differentiation of regulatory B cells  
Through their B cell receptors (BCR), B cells can respond directly to naïve 
antigen, which also enables an earlier involvement of Bregs in an immune 
response, when compared to regulatory T cells. It has been suggested that factors 
present in the microenvironment may play a crucial role in the induction of Breg 
cells (Gray, 2010). Toll-Like Receptors (TLRs) play a critical role in the early 
innate immune response to invading pathogens by sensing microorganisms in 
these microenvironments. 
Toll receptor was first identified in Drosophila melanogaster as an essential 
receptor for fungal infection by Christiane Nüsslein-Volhard in 1985 (Lemaitre, 
1996). After the discovery of Toll, its homologue Toll like-receptor (TLR4) was 
identified in mammals. Toll-like receptors can be activated via pathogen-
associated molecular patterns (PAMPs) and danger-associated molecular pattern 
molecules (DAMPs). Cytoplasmic domain of Toll resembles IL-1 receptor so it‟s 
named as TIR (Toll-IL-1 receptor) domain. TIR domain mediates intracellular 
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signaling. TLRs have leucine- rich repeats, which are required for ligand binding. 
There are 5 TIR adaptor molecules that play a role in signaling pathway: MyD88 
(myeloid differentiation primary response gene -88), Mal (MyD88-adapter -like), 
TRIF (TIR domain- containing adapter-inducing interferon- ), TRAM (Toll-like 
receptor 4 adaptor protein), and SARM (sterile alpha and HEAT/Armadillo motif). 
These adaptor proteins activate kinases and induce the secretion of cytokines by 
NF- B and MAPK pathways. TLR stimulation also leads to activation of 
JAK/STAT signaling pathway, which is important in cytokine secretion 
(Schindler, 2007). 
Lampropoulou et al. (2008) demonstrated that certain TLR agonists to be potent 
inducers of B cells with suppressive functions. In a mouse model of experimental 
autoimmune encephalomyelitis (EAE), LPS from Gram-negative bacteria and 
CpG-containing oligonucleotides that mimic bacterial DNA have been shown to 
inhibit disease progression by inducing IL-10-producing B cells whereas mice 
containing B-cell deletions of Tlr2, Tlr4 or the TLR adaptor myeloid 
differentiation primary-response gene 88 (MyD88). As a result, the mice could not 
recover from EAE  (Lampropoulou et al., 2008). This showed that TLRs are 
directly involved in modulating the regulatory function of B cells. TLR-signaling 
has been shown to initiate IL-10 production, however B cell receptor signaling is 
also critical for regulatory B cell development. In a study with CD19-deficient 
murine model, BCR activity was downregulated and results showed decreased 
regulatory B cell population (Kalampokis et al., 2013).  Accumulating data 
support a two-step model for the establishment of B-cell-mediated suppression. 
During the initial stage, TLR stimulation induces only a few IL-10-producing B 
cells. During the second phase, BCR and CD40 ligation, which are classically 
involved in B-cell survival and expansion, further amplifies the population of IL-
10-producing B cells, which results in sufficient IL-10 production for effective 
suppression (Lampropoulou et al., 2008). While IL-10 expression is considered 
central to the mechanism of Breg function, suggested that TGF-β may be equally 
important in the function of Bregs (Lee et al., 2014). 
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1.2.3.1 IL-10 producing regulatory B cells 
Regulatory B cells are present in several murine models of chronic inflammation, 
including collagen-induced arthritis (CIA), inflammatory bowel disease, and 
experimental autoimmune encephalomyelitis (Mauri, 2003;Mizoguchi, 
2002;Fillatreau, 2002). Their regulatory function appears to be directly mediated 
by the production of IL-10 and by the ability of B cells to interact with pathogenic 
T cells to dampen harmful immune responses (Mauri, 2008). IL-10 is a major anti-
inflammatory mediator that can be produced by numerous cell-types (Moore et 
al.,2001). In the early 90‟s, a particular subset of mouse B cells expressing CD5 
was shown to be an important producer of IL-10 in response to LPS (O‟Garra et 
al., 1992). Mainly located in the peritoneum, B1 cells largely contribute to the 
production of IgM antibodies, which play an important role as a first line of 
defense against bacterial and viral pathogens (Ochsenbein et al., 1999). Therefore, 
B1 cells represent a double edge sword with an innate arm against infection by 
producing T cell independent antibodies and with a potential regulatory role 
through the production of IL-10. Later, a unique CD1d
hi
CD5
+
CD19
hi
 subset, 
identified in spleens of naïve wild-type mice, is suggested as the Breg lineage that 
contributes to the majority of B cell IL-10 production, once activated by 
stimulation in vitro (Matsushita, 2011). Due to the fact that this novel B-cell 
subset only produces IL-10, they have been named B10 cells. Expression of IL-10 
and CD19 are the most widely used markers for IL-10 producing Bregs. The 
importance of regulatory B cells is demonstrated by the discovery of parallel B 
cells in humans. Miyagaki et al. reviewed the significance of regulatory B cells in 
mouse models of disease and extend these findings to what has been described in 
humans (Miyagaki et al., 2015). Nevetheless, in comparison to the wealth of data 
relating toTregs, little is known regarding the possible existence of Bregs in 
humans. It is clear that activated human B cells, similar to the mouse B cells, can 
produce significant quantities of cytokines that might influence the pathological 
environment (Pistoia, 1997; Harris et al., 2000). Depending on the signals B cells 
receive, pro- or anti-inflammatory cytokines can be produced. The cell-surface 
markers generally associated with Bregs are depicted in Table 1.1.  
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Table 1.1: Different Bregs with their surface markers and mechanisms of suppression. 
Subtype phenotype 
Mechanism of 
suppression 
References 
Phenotypes of mouse Breg subsets:   
T2-MZP B cells 
CD19+CD21hiCD23hiCD24hiIgMhiIgDhiC
D1dhi 
IL-10 Evans et al., 2007 
MZ B cells 
CD19+CD21hiCD23-
CD24hiIgMhiIgDloCD1dhi 
IL-10 Gray et al., 2007 
B10 cells CD19hiCD1dhiCD5+ IL-10 Yanaba et al., 2008 
B-1a cells CD5+ IL-10 O‟Garra et al., 1992 
Killer B cells CD5+CD178+ FasL Lundy, et al., 2009 
GIFT-15 B cells 
B220+CD21+CD22+CD23+CD24+ 
CD1d+CD138+IgD+IgM+ 
IL-10 Rafei et al., 2009 
Plasma cells 
CD138hiIgM+TACI+CXCR4+CD1dhiTim1
int 
IL-10, IL-35 Shen et al., 2015 
Plasmablasts CD138+CD44hi IL-10 
Matsumoto, et al., 
2014 
TIM-1+B cells - IL-10 Ding et al., 2011 
PD-L1hi B cells CD19+PD-L1hi PD-L1 Khan et al., 2015 
- B220+CD39+CD73+ Adenosine Kaku et al., 2014 
Phenotypes of human Breg subsets:   
Immature B cells CD19+CD24hiCD38hi IL-10, PD-L1 Blair et al., 2010 
B10 cells CD19+CD24hiCD27+ IL-10 Iwata, et al., 2011 
GrB+B cells CD19+CD38+CD1d+IgM+CD147+ GrB, IL-10, IDO Lindner et al., 2013 
Br1 cells CD25hiCD71hiCD73lo IL-10, IgG4 
van de Veen et al., 
2013 
Plasmablasts CD27intCD38hi IL-10 
Matsumoto et al., 
2014 
- CD39+CD73+ Adenosine Saze et al., 2013 
iBregs - TGF-β, IDO Nouël et al., 2015 
Tim-1: T cell Ig domain and mucin domain protein 1; PD-L1: Programmed death-ligand 1; GrB: 
granzyme B; IDO: indoleamine-2,3-dioxygenase. 
In contrast to autoimmune processes, these Breg are innate cells, which are 
activated and mobilized through the recognition of pathogen associated molecular 
patterns by TLR. The capacity of LPS to engage innate B cells with anti-
inflammatory properties raises the possibility of a regulatory role of B cells in 
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bacterial infections. It has been shown that CD5
+
 B cells produce IL-10 in 
response to LPS, to agonists of TLR2, 5, 7/8 and 9 (Sun et al., 2005; Zhang et al., 
2007).  It has been suggested that TLR2 agonists are specialized in inducing IL-10 
expression by antigen-presenting cells (APCs) (Agrawal et al., 2003; Dillon et al., 
2004; Netea et al., 2004; Hu et al.,2006). Following TLR ligation, signaling 
cascades are activated through Toll/IL-1 receptor (TIR)-domain-containing 
adaptor molecules, such as MYD88 and TIR-domain containing adaptor protein 
inducing IFNβ (TRIF; also known as TICAM1), leading to the production of IL-
10 and pro-inflammatory cytokines (Boonstra et al., 2006; Dillon et al., 2004; 
Hacker et al., 2006). TLR signaling through MYD88 leads to the activation of 
mitogen activated protein kinases (MAPKs) and NF-κB (Akira&Takeda, 2004). 
The MAPK cascade is composed of three major groups of kinases: extracellular 
signal-regulated kinases (ERKs) (comprising ERK1 (also known as MAPK3) and 
ERK2 (also known as MAPK1), which are collectively referred to here as ERK); 
JuN N-terminal kinases (JNKs) (comprising JNK1 (also known as MAPK8) and 
JNK2 (also known as MAPK9)); and p38 (Symons et al., 2006). Following TLR 
stimulation, activation of ERK modulates IL-10 expression, and in the presence of 
chemical inhibitors of ERK or in ERK-deficient cells IL-10 production by TLR-
activated DCs is decreased (Agrawal et al., 2006). 
 
Figure 1.4: TLR2 signaling pathways that induce IL-10 production (adapted from Saraiva 
& O‟Garra, 2010). 
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There are several direct and indirect mechanisms by which Breg cells exert their 
regulatory functions during the immune response (Figure 1.5). Regulatory B cells 
(Bregs) suppress activation and differentiation of CD4
+
, CD8
+
, and NK T cells 
primarily via the release of the anti-inflammatory cytokines IL-10 and TGF-β. 
Engagement of costimulatory pathways including CD154-CD40 and CD28-B7 are 
required for the release of IL-10 by Bregs. A Breg-T cell interaction results in an 
inhibition of T-cell activation and Th1 differentiation; induction of Tregs (Tr1); 
inhibition of DC activation, and hence suppression of T-cell activation; and 
clearance of apoptotic cells mediated via the release of autoreactive antibodies. B 
cells can also promote DCs to not only secrete IL-4 but also downregulate IL-12, 
which affects the Th1/Th2 balance (Moulin et al., 2000). The suppressive effect 
that Bregs exert on T cells might also provoke immune responses against 
autologous tumor cells. Moreover, transfer of a relatively low number of in vitro 
expanded Breg cells maintains long-term protection against several autoimmune 
diseases in animal models, which suggests that Breg cells can either further 
proliferate in vivo or initiate an efficient immunosuppressive cascade with other 
immune suppressive cells (Mauri, 2010). Breg cells can not only suppress effector 
T cell mediated immune responses but also convert effector T cells into regulatory 
Tr1 cells (Grammer et al., 2003; Gray et al., 2007; Carter et al., 2011). Gray et al. 
(2007) have clearly shown that apoptotic cells induce B and T cells to produce IL-
10.  
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Figure 1.5: Suppressive regulatory B-cell-mediated effector mechanisms in the 
immune response. Tr1, Type 1 regulatory cell(adapted from Mauri & Ehrenstein, 2007). 
1.2.3.2 TGF-β producing regulatory B cells  
Transforming growth factor-β (TGF-β) is another cytokine, which is shown to 
have regulatory function on cell response, proliferation and differentiation. It 
mainly has a role on inflammation and tolerance. TGF-β is first synthesized as 
pro-TGF-β and then it is cleaved by furin proprotein convertase in the Golgi 
apparatus to produce the dimeric propeptides called latency-associate peptide 
(LAP) that non-covalently associates with the dimeric mature TGF-β to prevent its 
activity. This complex can further associate with latent-TGF-β-binding protein 
(LTBP) to produce a large latent form for deposition onto the extracellular matrix 
(Taylor, 2009). Upon cell-cell contact with a potential target cell, cell surface LAP 
is stripped away and functionally active TGF- β1 becomes available for 
suppression.  
While IL-10 expression is considered central to the mechanism of Breg function, 
it is suggested that TGF-β may be equally important in the function of Bregs (Lee 
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et al., 2014). In a model of antibody-induced transplantation tolerance, Lee et al. 
(2014) showed that, Breg cells promote graft survival by promoting Treg-cell 
development, possibly via TGF-β production. According to their results, Breg 
cells express the TGF-β with latency-associated peptide (LAP) and Breg-cell 
mediated graft prolongation post-adoptive transfer is abrogated by neutralization 
of TGF-β activity. In addition to secreted TGF-β, the membrane-bound LAP/TGF-
β complex is shown to exert suppressive function as well (Xiao et al., 2012). It is 
hypothesized that the surface complex can stimulate TGF-β signaling in the target 
cell in a contact-dependent manner. 
In addition to IL-10-producing Breg cells, TGF-β1-producing Breg cells have 
been identified in response to LPS stimulation in vitro (Tian et al., 2011; Parekh et 
al., 2003). These B cells can trigger pathogenic Th1 cells to undergo apoptosis 
through Fas–FasL interactions and/or the inhibition of antigen-presenting cell 
activity via the secretion of TGF-β1 (Tian et al., 2011). Another study using a 
mouse model of prostate cancer has identified that IgA
+
 plasmocytes in the tumors 
can prevent tumor-directed cytotoxic T-cell functions, via the expression of IL-10 
and PD-L1 (Shalapour et al., 2015). Transforming growth factor (TGF)-β 
signaling and IgA class switch recombination were required for the development 
of this immune-suppressive Breg subset (Shalapour et al., 2015). As summarized 
in Table 1.1, iBreg suppression involves the production of TGF-β and IDO and 
induces the expansion of IL-10
+
 and TGF-β+ Tregs (Nouël et al., 2015). The 
expansion of iBregs requires stimulation with CTLA-4 by T cells. Collectively, 
the emerging roles of human Bregs in maintaining homeostasis emphasize the 
importance of this population in limiting inflammatory responses. 
1.3 T Cells 
T cell-mediated immunity is an adaptive process of developing antigen (Ag)-
specific T lymphocytes to defeat viral, bacterial, or parasitic infections. In 
addition, it may also involve aberrant recognition of self-antigens, leading to 
autoimmune inflammatory diseases. The antigen recognition through the T cell 
receptor (TCR) of unique antigenic peptides presented by MHC molecules on Ag-
presenting cells (APC) such as dendritic cells, macrophages and B cells gives the 
antigen specificity to the T cells (Figure 1.6). T cell-mediated immunity includes a 
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primary response by naïve T cells, effector functions by activated T cells, and 
persistence of Ag-specific memory T cells. The coordinated immune response 
includes other effector cells such as macrophages, natural killer cells, mast cells, 
basophils, eosinophils, and neutrophils (Broere et al., 2011). All T lymphocytes 
carry the cluster of differentiation markers (CD) CD45 and CD3. In addition, two 
commonly used CD molecules to indicate helper and cytotoxic T cells are CD4 
and CD8, respectively. 
 
Figure1.6: Antigen presentation to T cells. Antigen presentation stimulates T cells to become 
either "cytotoxic" CD8
+
 cells or "helper" CD4
+
 cells. Cytotoxic cells directly attack other cells 
carrying certain foreign or abnormal molecules on their surfaces. Helper T cells, or Th cells, 
coordinate immune responses by communicating with other cells. In most cases, T cells only 
recognize an antigen if it is carried on the surface of a cell by one of the body‟s own MHC, or 
major histocompatibility complex, molecules. 
Every effective immune response involves T cell activation. T cells require at least 
two signals to become fully activated. The first occurs after engagement of the T 
cell antigen-specific receptor (TCR) by the antigen-major histocompatibility 
complex (MHC), and the second by subsequent engagement of co-stimulatory 
molecules. The most potent T cell co-stimulator is CD28.  
TCR activation is regulated by various co-stimulatory receptors. One of the co-
stimulatory receptors, CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) 
proteins and provides an essential co-stimulatory signal during T-cell activation, 
which augments the production of IL-2 (Interleukin-2). The 28 co-stimulation 
increases T-cell proliferation and at the same time prevents the induction of 
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anergy and cell death. When CD28 is ligated by B7-1 or B7-2, it provides the T-
cell with an initial adhesion capable of approximating the T cell and antigen 
presenting cell membranes. Other than CD28, many other transmembrane 
receptors also modulate specific elements of TCR signaling. CD45 is one such 
receptor which regulates TCR signaling by antagonizing the inhibitory impact of 
inhibitory proteins, thereby favoring T-cell activation (Leupina et al., 2000). 
In order to keep a check on the hyperactivation of immune response associated 
with the pathway, negative regulation is also important. The transmembrane 
protein cytotoxic T-lymphocyte antigen-4 (CTLA4) serves as a natural inhibitor 
and negatively regulates T-cell activation. Since CTLA4 has a greater affinity for 
its B7-1/B7-2 ligands in comparison to CD28, after T-cell activation, CTLA4 is 
rapidly endocytosed, thus removing it rapidly from the cell surface. When a need 
to control TCR signaling arises, CTLA4 is again translocated to the membrane. At 
the membrane, CTLA4 inhibits the phosphorylation of TCR. Another mechanism 
by which CTLA4 might antagonize T-cell function is through inhibition of CD28 
signaling by competing for their shared ligands B7-1 and B7-2 
(Gough&Walker,2005). 
1.3.1 Naïve T cells 
After differentiating in bone marrow, and successfully undergoing the positive and 
negative processes of central selection in the thymus, T cells enter the bloodstream 
and migrate between blood and peripheral lymphoid tissue until they encounter 
their specific antigen. Mature recirculating T cells that have not yet encountered 
their antigens are known as naive T cells. Naïve T cells are commonly 
characterized by the surface expression of L-selectin (CD62L); the absence of the 
activation markers CD25, CD44 or CD69; and the absence of memory CD45RO 
isoform (De Rosa et al., 2001). On recognition of specific antigen, they undergo 
activation. Through their antigen-specific T cell receptor, they recognize specific 
antigenic peptides in the context of major histocompatibility (MHC) molecules. 
However, in addition to the cognate signal of the peptide-MHC complex 
interaction, T cells require additional co-stimulatory signals to complete T cell 
activation. APCs also provide co-stimulatory signals for effective T cell 
activation. 
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1.3.2 Activated T cells 
The activated T cells undergo clonal expansion and  rapidly proliferate, migrate to 
the sites of antigen, and perform effector functions such as cell-mediated 
cytotoxicity and production of various cytokines.  
1.3.2.1 Cytotoxic CD8+ T cells 
Cytotoxic CD8
+
 T cells (often called cytotoxic T lymphocytes, or CTLs) are very 
effective in direct lysis of infected or malignant cells bearing the antigen, and in 
tumor surveillance. CD8
+ 
T cells secrete anti-tumor and anti-viral cytokines such 
as TNF-α and IFN-γ. A second role of CD8+ T cells is that the production and 
release of cytotoxic granules which contain perforin and granzymes. Perforin 
forms a pore in the membrane of the target cell, similar to the membrane attack 
complex of complement. This pore allows the granzymes also contained in the 
cytotoxic granules to enter the infected or malignant cell. Granzymes are serine 
proteases which cleave the proteins inside the cell, shutting down the production 
of viral proteins and ultimately resulting in apoptosis of the target cell. Another 
important role of CD8
+
 T cells is the cell destruction of infected cells is via 
Fas/FasL interactions. Activated CD8
+
 T cells express FasL on the cell surface, 
which binds to its receptor, Fas, on the surface of the target cell. This binding 
causes the Fas molecules on the surface of the target cell which results in the 
activation of the caspase cascade, which also results in apoptosis of the target cell. 
In addition to their critical role in immune defense against viruses, intracellular 
bacteria, and tumours, CD8
+
 T cells can also contribute to an excessive immune 
response that leads to immunopathology, or immune-mediated damage (Liu& 
Lefrançois, 2004). 
1.3.2.2 CD4+ T cells 
CD4+ T cells are commonly divided into conventional T helper (Th) cells and 
regulatory T (Treg) cells. Th cells control adaptive immunity against pathogens 
and cancer by activating other effector immune cells; while Tregs are defined as 
CD4+ T cells in charge of suppressing potentially deleterious activities of Th 
cells. 
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CD4
+
 T helper cells 
The T helper cells (Th cells) play an important role in the adaptive immune 
system, by helping the activity of other immune cells by releasing T cell 
cytokines. At first, based on transcription factors and cytokine production, 
Mossman and Coffman depicted two main classes of helper cells: Th1 and Th2 
(Mosmann et al. 1986). While investigating the role of IL-12, a Th1 promoting 
cytokine in a murine model of EAE, Cua et al. surprisingly found that elimination 
of IL-12 exacerbated disease. IL-12 is composed of p35 and p40 subunits. IL-23, 
an IL-12 family member, also utilizes p40, but is completed by the p19 subunit. 
Realizing this, Cua demonstrated the elimination of IL-23 specific p19, but not 
p35 (IL-12), protected the mice from disease onset. Thus, a third T Helper class 
was discovered and referred as Th17 Cells (Cua et al. 2003).  
 
Figure 1.7: CD4
+ 
T helper subsets with their effector cytokines. CD4+ T cells can differentiate 
into different subsets depending on the cytokine milieu present during T cell activation. 
Th1 cells are involved with intracellular defense, essential to cell-mediated 
immunity, that drive the killing efficacy of macrophages and proliferation of 
cytotoxic CD8
+
 T cells in response to intracellular pathogens. Th1 cells are 
characterized by the expression of the transcription factor T-bet and produce 
cytokines: IL-2, IFN-γ, TNF, and LT-α. Th1 cells are associated with several 
chronic inflammatory diseases, including multiple sclerosis, diabetes, and 
rheumatoid arthritis (Romagnani, 1999). 
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Th2 cells are polarized by IL-4 cytokine and stimulate the humoral response to 
infections, including B cell proliferation, class-switching, and increased antibody 
production. Th2 cells express the transcription factor GATA3 and produce IL-4, 
IL-5, IL-6, IL-10, and IL-13. Th2 cells are associated with several inflammatory 
conditions, including allergy and asthma (Romagnani, 1999). 
Th17 cells are a unique subset of activated T helper cells that have been found to 
be vital in extracellular pathogen defense at epithelial and mucosal barriers. In a 
Helicobacter felis infection model, MyD88 was required for Th17 development 
(Obonyo, 2011). MyD88 is a universal adapter protein used by TLRs to activate 
NF-kB signaling, suggesting a role for TLR activation in Th17 development. 
Studies have shown convincingly that TGF-β is required for Th17 differentiation 
in vitro and in vivo. The development of aTh17 response is promoted by TGF-β, 
IL-1β, and IL- 6 and further expanded and activated by IL-23. IL-23regulates the 
secretion of IL-17 through at STAT3 dependent pathway (Carusoetal.,2008).  IL-
23 induced activation of STAT3 leads to direct binding of phosphorylated STAT3 
to IL-17A and IL-17F promoters(Chen etal.,2006).  Moreover, STAT3 up-
regulates the expression of Retinoic Acid Receptor-Related Orphan Receptor 
Gamma-T (ROR-γ), a Th17 specific transcriptional regulator that is critical for the 
expression of two members of IL-17A and IL-17F (Chen et al., 2007b; Laurence 
and O‟Shea ,2007; Yang et al., 2007). IL-17A is associated with gastric 
inflammation during H. pylori infection and, when the infection becomes chronic, 
this cytokine may contribute to the inflammation-associated carcinogenesis 
(Kabir, 2011; Resende et al., 2011).  Th17 cells have been associated with the 
pathogenesis of several chronic inflammatory disorders, including rheumatoid 
arthritis and multiple sclerosis (Langrish, 2005;  Hirota et al. 2007). However, 
there are some reports that Th17s can maintain a protective effect, particularly in 
the gut (Annunziato  et al., 2008). It was shown that although TGF-β and IL-6 
drive initial Th17 lineage commitment, the pathogenic potential of Th17 cells are 
restained by the coproduction of IL-10. Only when the Th17 cells are exposed to 
IL-23 they cease IL-10 production and attain their full pathogenic function 
(McGeachy et al., 2007). Esplugues et al. found that Th17 cells are controlled by 
two different mechanisms in the small intestine: first, they are eliminated via the 
intestinal lumen; second, pro-inflammatory TH17 cells simultaneously acquire a 
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regulatory phenotype with in vitro and in vivo immune-suppressive properties 
(rTH17) (Esplugues et al., 2011).  
A brief information about the other helper T cells can be found in Table 1.2. 
Table 1.2: T helper cell subsets with their effector cytokines and functions. 
Name Effector 
Cytokine 
Function 
T helper 9 
(Th9) 
IL-9, IL-10 Host defense against extracellular parasites, primarily 
nematodes. Despite their production of anti-inflammatory 
IL-10, they promote allergic inflammation. Their role in 
other inflammatory diseases still remains unclear as this 
subset has only recently been characterized. 
T helper 22 
(Th22) 
IL-22 Identified in inflammatory skin diseases. Their role in host 
defense remains unclear as this subset has only recently 
been characterized. Their identity as an independent TH 
cell subset needs to be confirmed. 
T follicular 
helper 
(Tfh) 
IL-21 Involved in promotion of germinal center responses and 
provide help for B cell class switching. 
Regulatory CD4
+
 T cells 
The idea of a naturally occurring T cell subset with suppressive function that 
limits the outcome of autoimmune responses was first described in the 1970s by 
Gershon (Gershon, 1975). The role of regulatory T cells is to maintain the balance 
between self-tolerance, pathogen clearance, and autoimmunity. These cells 
generally suppress or downregulate induction and proliferation of effector T 
cells. The discovery of Foxp3 as a specific marker of natural T regulatory cells 
and adaptive/induced T regulatory cells (a/iTregs) gave a molecular anchor to the 
population of regulatory T cells (Tregs), previously identified by non-specific 
markers such as CD25 or CD45RB (Hori et al., 2003; Fontenot et al., 2003, 2005).  
FOXP3 (Forkhead box protein P3) is a 50-55 kD transcription factor and is 
proposed to be a master regulatory gene and is considered as a specific marker of 
T regulatory cells more than most cell surface markers (Ramsdell&Ziegler, 2014). 
Genome-wide analysis has shown that Foxp3 binds to the promoter region of 700-
1000 genes, many of those genes being associated with TCR signaling (Marson et 
al., 2007; Zheng et al., 2007). Although it was thought to be a critical factor for 
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Treg function, it was observed that Foxp3 was not expressed by T regulatory cells 
1 (Tr1), a Treg subset which is induced by IL-10 and which produces IL-10 
(Groux et al., 1997; Levings et al., 2005).Two major classes of CD4
+
 Treg cells 
have been described: FOXP3
+
 Treg cells and FOXP3
−
 Treg cells. On the other 
hand, in some studies it is suggested that presently used Treg markers (CD25, 
CTLA-4, LAG-3 and Foxp3) represent general T cell activation markers rather 
than being truly Treg-specific. Recent reports have demonstrated that Foxp3+ 
Tregs may differentiate in vivo into conventional effector Th cells, with or without 
concomitant downregulation of Foxp3. Treg cells induced by TGF-β in vitro were 
shown to lose Foxp3 expression and suppressive activity upon restimulation in the 
absence of TGF- β (Floess et al., 2007). Futhermore, it is suggested that Bregs 
could increase Treg numbers by expanding existing Treg populations or 
converting naïve Foxp3- T cells into Foxp3+ Tregs (Lee et al., 2014). 
 
Figure 1.8:Different subsets of Treg cells. The naturally occurring 
CD4
+
CD25
+
FOXP3
+
 Treg (nTreg) cells are generated in the thymus, whereas three 
different subsets of inducible Treg (iTreg) cells can be generated in the periphery: (i) 
FoxP3
+
Treg cells, (ii) CD4
+
FoxP3
−
 IL-10–producing Tr1 cells and (iii) TGF-β-expressing 
TH3 cells. 
Natural Regulatory T cells 
Naturally occuring Tregs (nTregs) are characterized by the expression of CD4, 
CD25 and Foxp3, which is a transcription factor important in the development of 
Tregs. nTregs (CD4
+
CD25
+
FoxP3
+
) are mainly derived as a functionally mature 
subset from the thymus. Studies suggest that relatively higher avidity thymic 
stromal interactions between the TCR and self-peptide of nTregs as well as FoxP3 
play crucial roles in nTreg development. Suppressive mechanisms of nTregs 
which is thought to be by cell to cell contact involve cytotoxic killing, induction of 
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other regulatory cells, APC function downregulation, transduction of suppressive 
signals through B7 molecules on target T cells, as well as other negative signals 
produced by inhibitory nTreg surface molecules. Subsequent in vitro studies 
showed that this population, now referred to as CD4
+
CD25
+
 T regulatory cells, is 
both anergic and suppressive (Thornton, 1998; Takahashi et al., 1998; Read et al., 
1988). 
Induced Regulatory T cells 
In addition to nTregs, there are several distinct subsets of induced regulatory T 
cells (iTregs). The well-known iTregs are Tr1 and Th3, but studies reveal other 
induced regulatory T cells continuously. Not recently was shown the existence of 
IL-10 and IL-17 co-producing T cell subset. The inducible regulatory T cells are 
generated from naive T cells in the periphery. Tr1 cells mediate their suppression 
mainly though the production of IL-10, while Th3 cells mediate suppression 
through TGF-β production (Lan, 2003).  
Experiments showed that orally immunized mice in whom oral tolerance has been 
induced manifest T cells that produce TGF- β1, co-called Th3 cells and that T 
cells that lines that produce IL-10, so-called Tr1 T cells, can prevent development 
of colitis in SCID-transfer mouse model (Chen, 1994; Groux, 1997). Additionally, 
in vivo studies using conditional knock-out mouse strains revealed that IL-10 
production by T cells, but not B cells, was essential for the suppression of 
excessive gastric immunopathology (Sayi et al, 2011). 
Foxp3+ iTreg cells 
While natural Foxp3
+
 nTregs are directly released from the thymus independent of 
APCs (Kyewski and Klein, 2006; Ohkura and Sakaguchi, 2010), conversion of 
Foxp3
+
 iTregs occurs in peripheral lymphatic organs with interaction with APCs. 
The basal requirements for the development of Foxp3
+
 iTregs in vitro and in vivo 
are defined by TCR signalling and the presence of the cytokines IL-2 and TGF-β 
(Fantini et al., 2004; Davidson et al., 2007; Curotto de Lafaille and Lafaille, 
2009). 
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Th3 cells 
Th3 iTregs, which are characterized by the production of TGF-β, occur primarily 
after ingestion of a foreign antigen via the oral route. The presence of TGF-β, 
which is found at high levels in the bowel, helps induce the differentiation of 
naive T cells into Th3 cells (Berthelot et al.,2004). Th3 cells, like nTregs, express 
CTLA-4 on their surface, the triggering of which results in the secretion of TGF-β. 
FoxP3 and CD25 expression is also upregulated after restimulation of TGF-β 
induced Th3 cells. Unlike nTregs, the main suppressive mechanism of Th3 cells is 
dependent on the production of TGF-β, which suppresses the proliferation of Th1 
and Th2 cells.  
Type 1 regulatory T cells (Tr1)  
In 1997 so-called type 1 regulatory T cells (Tr1) were identified as a subset of 
CD4
+ 
cells that produces high levels of IL-10, low levels of IL-2 and no IL-4 
(Groux et al., 1997).  In contrast to nTregs, Tr1 cells do not express high levels of 
CD25 or FoxP3, and do not mediate suppression via cell–cell contact (Berthelot et 
al., 2004). The cytokine profile of Tr1 cells include high levels of IL-10 and lower 
levels of TGF-β and IFN-Ɣ (Levings, 2004). IL-10, and debatably TGF-β, take 
place in Tr1 mediated suppression of the proliferation and cytokine production of 
other T cell subsets (Mills, 2004; Roncarolo, 2001; Stassen, 2004).  
As mentioned before, H. pylori uses a variety of mechanisms to inhibit the T-cell 
response and persist in the gastric mucosa. Tregs are induced during infection, 
which express the inhibit other T-cell responses by producing IL-10 and TGF-β 
(Beswick, 2007; Oertli, 2012). Using mouse models of infection with 
Helicobacter felis, a close relative of the human gastrointestinal pathogen H. 
pylori, Sayı et al. showed that B cells activated by Helicobacter TLR-2 ligands 
induce IL-10–producing CD4+CD25+ T regulatory-1 (Tr-1)–like cells in vitro and 
in vivo. According to their results, Tr-1 conversion depended on TCR signaling 
and a direct T-/B-interaction through CD40/CD40L and CD80/CD28. They 
suggested that B cell-induced Tr-1 cells acquire suppressive activity in vitro and 
suppress excessive gastric Helicobacter-associated immunopathology in vivo. 
Furthermore, Gagliani and her research group identified the surface markers 
CD49b and lymphocyte activation gene 3 (LAG-3) as being stably and selectively 
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co-expressed on mouse and human Tr1 cells (Gagliani et al., 2013). CD49b is 
expressed by Tr1 cells irrespective of their activation, whereas LAG-3 is 
expressed on Tr1 cells when they produce IL-10 and have suppressive activity. 
Co-expression of CD49b and LAG-3 distinguishes Tr1 cells from Th1, Th2 and 
Th17 cells (Gagliani et al., 2013). 
1.3.3 Effects of IL-10 on T Cell Differentiation 
IL-10 was first described as a cytokine that is produced by Th2 cell clones 
(Fiorentino, 1989). It inhibits IFN-γ synthesis in Th1 cell, and therefore it was 
initially called cytokine synthesis inhibiting factor (CSIF) (Delves et al., 1998).  
Later, evidences suggested that IL-10 production was associated with many 
immune cell types including Tregs and Bregs. 
As summarized in Figure 1.9, IL-10 produced and secreted by regulatory B cells 
work on many cellular regulation. It is suggested that the balance between Th1 
and Th2 response is accomplished by IL-10.  This cytokine also claimed to inhibit 
Th1 and Th17 response while inducing Foxp3
+
 Treg cells and IL-10 producing 
Tr1 cells. Another aspect of IL-10 influence is the repression of antigen 
presentation. Causing a decrease in the expression of MHC-II molecules or co-
stimulation molecules such as CD86, IL-10 indirectly suppresses antigen 
presentation to the T cells (Figure 1.9) (Yang et al., 2013). IL-10 produced by 
TLR2-activated B cells has also been implicated with their potency to convert 
CD4
+
 T cells into IL-10 producing Tr-1 cells, in vitro in a contact-dependent 
manner (Sayi et al.,2011). 
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Figure 1.9: Immune functions of IL-10 secreted by regulatory B cells (adapted from 
Yang et al., 2013). 
Although in the presence of IL-10, CD4
+
 T cells are induced to develop a 
regulatory phenotype in vitro that suppress antigen-specific effector T cell 
responses via a cytokine-dependent mechanism, it is suggested that the effects of 
IL-10 on APCs play a more important role in the development of Tr1 than the 
direct influence on the CD4
+
 T cells (Groux et al.,1997). Furthermore, IL-10 is 
also capable of limiting Th1- and Th17-mediated immune responses by reducing 
the secretion of IL- 12 and IL-23 from APCs, respectively. IL-12 is the cytokine 
responsible for Th1- type T cell conversion from naive CD4+ T cells whereas IL-
23 is known to be pivotal for Th17 immune response.  As mentioned above, 
independent of its inhibitory effect on APCs,  IL-10 inhibits directly both the 
proliferation and the cytokine synthesis of CD4
+
 T cells, including the production 
of IL-2 and IFN-g by Th1 and of IL-4 and IL-5 by Th2 (Sabat et al., 2010).  
Breg cells have been shown to affect the balance between Foxp3
+ 
and IL-17–
producing T cells(Carter et al., 2011 Tedder et al., 2010). Carter et al. have 
demonstrated that endogenous IL-10-producing B cell-deficient mice develop an 
exacerbated case of arthritis and exhibit an increased frequency of Th1/Th17 pro-
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inflammatory cells, but a decreased frequency of Treg cells (Carter et al., 2011; 
Carter et al., 2012). Consistent with these findings, Yang et al. have also 
demonstrated that B10 cells induced in vitro can suppress Th17 cell differentiation 
by decreasing the phosphorylation levels of  Stat3, which subsequently reduces the 
levels of ROR γ t, and partially inhibits the Th17 cell population in an IL-10-
dependent manner (Yang et al., 2012). Based on these current findings, it has been 
shown that Breg cells play an important role in T-cell plasticity. 
1.3.4 Effects of TGF-β on T Cell Differentiation 
TGF-β promotes T-cell survival by inhibiting activation-induced cell death and 
blocks T-cell proliferation by inhibiting IL-2 production (Brabletz, 1993; Li, 
2006). Through its effects on T-helper (Th)-cell differentiation, TGF-β modulates 
T-cell activation (Li, 2006). TGF-β also promotes Treg-cell development while 
inhibiting Th1- and Th2-cell development (Chen, 2003; Horwitz 2003).  In a 
model of transplant tolerance, Lee et al. (2014) aimed to identify soluble factors 
produced by B cells that might explain their Treg-cell inducing activity and they 
hypothesized that regulatory B (Breg) cells could contribute to regulatory T-cell 
induction by producing TGF-β. Starting with sorted Foxp3− T cells in an allergic 
airway disease model, Singh et al. (2008) demonstrated in vitro that co-culture 
with Breg cells could induce Foxp3 expression upon activation by anti-CD3 and 
anti-CD28 in a TGF-β-dependent manner.  Another important TGF-β activity for 
Tregs is to mediate the immunosuppression to maintain the peripheral tolerance 
(Nakamura et al., 2004; Bommireddy et al., 2007).  It has also been reported that T 
cell proliferation is suppressed by regulated cell cycle activity through TGF-β. 
Furthermore, pro-inflammatory cytokines such as IFN-γ was regulated by this 
cytokine. It helps to differentiation of Foxp3
+
 Treg cells, as well (Wrzesinski et 
al., 2007). Therefore, TGF-β leads to inhibition of Th1 and Th2 cells and also 
blockade of cytotoxic T cell activation. On the other hand, it triggers Treg 
differentiation together with Th17 activation (Figure 1.10) (Banchereau, Pascual 
& O‟Garra, 2012). Studies have shown convincingly that TGF-β is required for 
Th17 differentiation in vitro and  in vivo. The development of aTh17 response is 
promoted by TGF-β, IL-1β, and IL- 6 and further expanded and activated by IL-
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23. IL-23regulates the secretion of IL-17 through at STAT3 dependent pathway 
(Caruso et al.,2008).   
 
Figure 1.10: Role of TGF-β on immune cells. In order to assess the role of TGF-β, TGF-β - 
knockout mice were used in different studies. In the absence of this cytokine, mice showed 
multifocal inflammatory function (adapted from Banchereau, Pascual & O‟Garra, 2012). 
1.4 Innate and adaptive immunity against Helicobacter 
Helicobacter induces both humoral and cellular immune responses. Local and 
systemic antibody responses include IgA, IgM, and IgG istotypes (Crabtree et 
al.,1991). Early mouse model studies demonstrated that immunization with H. 
pylori antigens could produce protective immunity (Marchetti et al., 1995).  H. 
pylori causes an inflammatory reaction with both polymorphonuclear and 
mononuclear cells (Goodwin et al., 1986), and gastric mucosa of infected patients 
contains increased levels of proinflammatory cytokines such as IL-1β, tumor 
necrosis factor (TNF)-α, IL-8, and IL-6 (Crabtree et al., 1993). On the other hand, 
Helicobacter has developed a variety of mechanisms to persist in the gastric 
mucosa. Gastric epithelial cells (GECs) are primary target for H. pylori infection, 
therefore they are the first point of contact for H. pylori and activate an innate 
immune response through TLRs. Though, H. pylori differs from other 
gastrointestinal pathogens. Due to mutations in the TLR5 recognition site of the 
N-terminal D1 domain of flagellin (Andersen-Nissen et al., 2005), H. pylori 
flagellin is a poor ligand of TLR5 (Gewirtz etl al., 2004). Furthermore, rather than 
being a strong TLR4 ligand, H. pylori  LPS is thought to activate TLR2 on gastric 
epithelial cells (Smith et al., 2003; Chaouche-Drider et al., 2009). Animal and cell 
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culture experiments suggested that ligands in Helicobacter species can bind to 
TLR2 and activate NF-κB in epithelial cells (Chaouche-Drider et al., 2009; Sayi et 
al., 2011).  
 
Figure 1.11: Schematic demonstrating how dendritic cells may bridge the innate and 
adaptice immune response directed against H. pylori within the gastric mucosa (adapted 
from Peek et al., 2010). 
H. pylori infection stimulates the activation of epithelial cell, macrophage, and 
DC, as well as a Th1 predominant lymphocyte response. The line separating the 
innate from the adaptive response is vague. B cells can respond to H. 
pylori directly, or via the interaction of activated T cells, illustrates the complexity 
of the host immune response. Colonization of H. pylori can be abrogated by 
immunization with bacterial components such as urease (Panchal et al., 2003), 
indicating activation of the adaptive response, but urease is also a major inducer of 
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innate responses in monocytes and macrophages, stimulating cytokine and nitric 
oxide generation (Gobert  et al., 2002; Mai et al., 1992).  
As a characteristic feature of Helicobacter infection, neutrophils or 
polymorphonuclear leukocytes (PMNs) migrate to the site of the infection and 
trigger an inflammation which still cannot clear the infection due to the ability of 
the bacteria to survive by manipulating phagocytosis and the subsequent oxidative 
burst.  Direct interactions between gastric epithelial cells and H. pylori or H. 
pylori urease can also activate PMN cells and/or macrophages, which further 
amplifies the T-cell response. The neutrophil-activating protein (NAP) of H. 
pylori contributes to Th1 polarization by stimulating both IL-12 and IL-23 
secretion from neutrophils and monocytes (Amedei et al., 2006).  
Other essential innate responders to H. pylori related products are the epithelial 
cells that are in direct contact with the bacterium on the surface of the mucosa and 
the  macrophages which also function as effector cells in host defense by their 
nitric oxide secretion.  Monocytes and macrophages, along with DCs, coordinate 
the  immune responses to  H. pylori as activators of adaptive immunity by 
producing factors such as IL-12 (Haeberle et al., 1997; Meyer et al., 2003) . IL-12 
stimulates Th1 cells, resulting in production of cytokines such as IFN-γ which is 
linked to the development of peptic ulcers in infection with H. pylori cag
+
 strains 
(Hida et al., 1999). Macrophages are also involved in amplification of the 
inflammatory response by production of cytokines such as IL-1, TNF-α, and IL-6 
(Harris et al., 1998), and IL-6 activation has been linked to activation of TLR4, 
MAPK, and NF-κB signaling events (Pathak et al., 2006). 
It has been shown that DCs are primary responders to stimuli including bacterial 
products and have an important duty as APCs. DCs can engulf bacteria directly by 
penetrating epithelial monolayers in vitro and the intestinal epithelial barrier in 
vivo (Chieppa et al., 2006; Niess et al., 2005; Rescigno et al., 2001). Thus, being 
capable of inducing either a Th1, Th2/regulatory T cell (Treg), or a Th17 response 
by generation of interleukin (IL)-12, IL-10, or IL-23, respectively, they activate T 
cells in different ways.  
Furthermore, B cells also contribute to the immunopathogenesis of H. pylori 
infection. In studies conducted in B cell-deficient (μMT) mice infected with H. 
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pylori, when compared with wild-type mice, there was no difference in 
colonization at 2 wk after infection, but a 2 log-fold reduction developed at 8 and 
16 wk postinoculation, that was associated with increased gastric inflammation 
and infiltration of CD4
+
 T cells (Akhiani et al., 2004). While IgG and IgA 
responses to H. pylori in the serum and gastric mucosa may be involved in 
protective immunity, the latter study, and another by the same group implicating 
the negative effect of IgA antibodies (Akhiani et al., 2005), suggests that B cell-
mediated antibody responses may be counterproductive. 
The importance of IL-12  that may be produced from  monocytes, macrophages, 
or DCs in the induction of Th1 lymphocyte response (Guiney et al., 2003; Hafsi et 
al., 2004) and the role of gastric epithelial cells as antigen presenting cells in 
activation of CD4
+
Th cells (Ye et al., 1997) has been shown. Moreover, mucosal 
T cells harvested from  H. pylori-infected hosts produce abundant levels of the 
Th1 cytokines IFN-γ and IL-2 and low levels of the Th2 cytokines IL-4 and IL-5 
(Bamford et al., 1998). 
As another T cell response, IL-17 has been linked to chemokine-mediated 
neutrophil infiltration, and IL-17 levels are increased in H. pylori-infected human 
(Luzza et al., 2008) and mouse (Scott et al., 2007) gastritis tissues. Recently, it has 
been shown that immunization of mice with H. pylori lysate markedly enhanced 
IL-17 expression in the gastric mucosa and in CD4
+
T cells isolated from spleens 
and co-cultured with H. pylori-stimulated DCs or macrophages. The results 
indicated  increased gastric inflammation and decreased colonization (DeLyria et 
al., 2009). Taken together, it is suggested that the attenuated cytokine/chemokine 
response in unimmunized mice suggest that the IL-17/Th17 response may be 
defective in a normal host, thereby contributing to chronic persistence of the 
bacterium.  
Beside effector T cell responses, Tregs are shown to be crucial in the pathogenesis 
of H. pylori infection. In an study of H. pylori-infected humans, Lundgren et al. 
(2003) showed that H. pylori-specific Tregs suppress memory T-cell responses 
and could thus contribute to the persistence of the infection. It has been reported 
that H. pylori-infected individuals have increased levels of CD4
+
CD25
high
 T cells 
in the gastric and duodenal mucosa that express mRNA of FOXP3, a gene 
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involved in the development of Tregs, and high levels of the CTLA-4 protein. 
Meanwhile, more CD4
+
CD25
high
 T cells were observed in H. pylori-associated 
gastric adenocarcinoma tissues than the adjacent tissue (Lundgren et al., 2005). 
Along with gastric cancer, differences in the number of regulatory T cells have 
been identified in patients with and without peptic ulcer disease. Robinson et al. 
(Robinson et al., 2008) reported that H. pylori-infected persons with peptic 
ulceration had significantly less gastric regulatory T cells but increased Th1 and 
Th2 responses compared with infected subjects without ulcers, suggesting that 
imbalances within the regulatory T-cell network may predispose to diseases that 
develop within the context of H. pylori infection. 
1.5 Interaction between Helicobacter-activated B cells and T cells 
Helicobacter has developed a variety of mechanisms to persist in the gastric 
mucosa. Gastric epithelial cells (GECs) are primary target for H. pylori infection, 
therefore they are the first point of contact for H. pylori and activate an innate 
immune response through TLRs. Though, H. pylori differs from other 
gastrointestinal pathogens. Due to mutations in the TLR5 recognition site of the 
N-terminal D1 domain of flagellin (Andersen-Nissen et al., 2005), H. pylori 
flagellin is a poor ligand of TLR5 (Gewirtz etl al., 2004). Furthermore, rather than 
being a strong TLR4 ligand, H. pylori  LPS is thought to activate TLR2 on gastric 
epithelial cells (Smith et al., 2003; Chaouche-Drider et al., 2009). Animal and cell 
culture experiments suggested that ligands in Helicobacter species can bind to 
TLR2 and activate NF-κB in epithelial cells (Chaouche-Drider et al., 2009; Sayi et 
al., 2011).  
B cells and their cytokines have important roles in Helicobacter infections by 
balancing between the infection and T cell driven gastric immunopathology. The 
ability of B cells to interact with pathogenic T cells and to produce anti-
inflammatory cytokines such as IL-10 is crucial to dampen harmful immune 
responses (Mauri, 2008). It has been found that B-cells exposed to Helicobacter 
extract produced large amounts of the regulatory cytokine IL-10 (Sayi et al., 
2011). Using mouse models of Helicobacter-induced gastric premalignant 
pathology, Sayi et al.(2011) showed that IL-10 secretion by purified B cells 
absolutely required MyD88 signaling and TLR-2, as B cells isolated from the 
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respective MyD88−/− and TLR-2−/− animals failed to respond to the stimulations. 
In addition, their results indicated that the upregulation of surface CD80 and 
CD86 on B cells and the antibody secretion, was largely dependent on MyD88 and 
TLR-2 (Figure 1.12).  
The TLR-2 dependent Helicobacter activation of B cells differentiates them into 
IL-10 and TGF-β producing regulatory B cells. As explained in the previous 
sections, both IL-10 and TGF-β have crucial effects on T cell differentiation. 
When co-cultured with Helicobacter-activated B cells, naive CD4
+
 T-cells are 
shown to produce IL-10 and differentiate into T regulatory 1 (Tr1)-like cells (Sayi 
et al, 2011). In addition to that, Lee et al. (2014) suggested that Breg cells 
contribute to regulatory T-cell induction by producing TGF-β. At the same time, 
studies have shown convincingly that TGF-β is required for Th17 differentiation 
in vitro and in vivo (Caruso et al.,2008).   
 
Figure 1.12: One suggested interaction between Helicobacter-activated B cell and T cell. 
Helicobacter TLR-2 ligands activate B-cells in a MyD88-dependent manner, which leads 
to the expression and surface exposure of CD80, CD86, and CD40, and the secretion of 
IL-10, IL-6 and TNF-a as well as antibodies of the IgM and IgG2b subclasses. The 
interaction of activated B-cells and naive T-cells induces T-cellular IL-10 expression and 
suppressive activity in a manner dependent on a direct interaction between both cell types 
via CD40/CD40L, B7/CD28 and MHCII/TCR. IL-10 secreting T-cells are essential 
players in the prevention of Helicobacter-associated immunopathology (Sayi et al, 2011). 
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1.6 Aim of the study 
The immune response mechanisms against Helicobacter pylori involve both 
protective and damaging effects for the host. Results of many studies suggested a 
crucial role for B cells in Helicobacter infection that balances between the 
infection and T cell mediated pathology. Helicobacter induces B cells to produce 
and secrete IL-10 which is suggested to have a role in the differentiation of naïve 
CD4
+ 
T cells into suppressive IL-10 producing Tr-1-like cells (Sayi et al.,2011); 
while other studies revealed the importance of TGF-β in both Tr-1 and Th17 
differentiation (Lee at al., 2014; Caruso et al., 2008). 
In previous studies in our laboratory, colleagues separated the Helicobacter-
activated B cells into two subgroups: Helicobacter-activated IL-10
+
 B cells and 
Helicobacter-activated IL-10
-
 B cells. The experimental results showed that 
Helicobacter-activated IL-10
+
 B cells are the source of the IL-10 production while 
Helicobacter-activated IL-10
-
B cells are mostly TGF-β positive. However, it was 
not clear if the Helicobacter-acitvated-IL-10
+
 B cells or the Helicobacter-
activated-IL-10
-
 B were specifically causing the Tr1 differentiation. Taking 
account that Bregs are known for producing IL-10 and TGF-β which are key 
cytokines in T cell differentiation, and focusing on these cytokines produced by 
Helicobacter-activated B cells as well as the cell-to-cell contact, in this study the 
role of Helicobacter-acitvated-IL-10
+
 B cells and the  Helicobacter-activated-IL-
10
- 
B cells on CD4
+
 T cell differentiation was investigated. 
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2.  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Bacteria 
Helicobacter felis (H. felis) strain was kindly provided by Prof. Dr. Anne Müller 
from University of Zurich. Bacteria are planted on Columbia Agar plates 
supplemented with 1000X antibiotic cocktail. Ingredients of Columbia Agar (BD, 
U.S.A.) plate and 1000X antibiotic cocktail were given in Table 2.1 and Table 2.2, 
respectively.  
Table 2.1: Components of Columbia Agar Plates. 
Component Amount 
Columbia Agar 42,5 g 
Horse Blood 50 ml 
β-cyclodexin 10 ml 
1000X Antibiotic Cocktail 1 ml 
Table 2.2: Components of 1000X Antibiotic Cocktail. 
Content Amount 
Trimethoprim 100 mg 
Amphotericin B 160 mg 
DMSO 20 ml 
2.1.1.1 Antibiotics 
Antibiotics that are used in Helicobacter felis culture are listed in Table 2.3. 
Table 2.3: Antibiotics used in Helicobacter felis culture. 
Content Supplier Company 
Trimethoprim HiMedia 
Amphotericin B HiMedia 
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2.1.1.2 Liquid culture 
Ingredients of liquid culture of Helicobacter felis are shown in Table 2.4 with a representative 
volume of 50 ml. The volumes of the ingredients may change with the same ratio. 
Table 2.4: Components of Helicobacter felis liquid culture. 
Content Amount 
Brucella Broth 50 ml 
FBS [10% (v/v)] 5 ml 
Vancomysin (1000X) 5 µl 
2.1.1.3 Freezing of Helicobacter felis 
Helicobacter felis freezing medium ingredients are given in Table 2.5 with its ingredients. 
Upon preparation the medium can be stored at 4°C. 
Table 2.5: Freezing medium for Helicobacter felis. 
Component Amount 
Brucella Broth 25 ml 
Glycerol 25 ml 
2.1.2 Primary cell lines 
2.1.2.1 CD19
+ 
 B cells 
Splenic CD19
+
 B cells were isolated from C57BL/6 mice via magnetic separation (Macs 
Miltenyi, Germany). Primary B cells were cultured in Roswell Park Memorial Institute 
(RPMI) medium supplemented with 10% FBS, 1% Penicillin/Streptomycin. A part of the 
purified CD19
+ 
B cells were stimulated with Helicobacter felis sonicate.  
2.1.2.2 CD4
+
 T cells 
Splenic CD4
+
 T cells were isolated from the spleens of C57BL/6 mice via magnetic 
separation (Macs Miltenyi, Germany). To maintain the viability of CD4
+
 T cells in the 
culture, recombinant IL-2 (10 ng/ml, MACS, Militenyi) and anti-CD3Ԑ antibody ( 1 mg/ml, 
17A2, Militenyi Biotech) is added inside the completed (10% FBS, 1% Pen/Strep) RPMI 
culture media. 
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2.1.3 Cell culture 
Buıffers that were used in cell culture studiesare given in Table 2.6 while culture media and 
solutions that have been used in cell culture studies are listed in Table 2.7. 
Table 2.6: Buffers used in cell culture studies. 
Buffer Content and Amount 
PBS 1X 9,55 g in 1L ddH2O 
MACS Buffer 0.5% BSA + 2 mM EDTA in PBS 1X 
FACS Buffer 2% FBS in PBS 1X 
Table 2.7: Solutions and media used in cell culture studies. 
Solution Supplier Company 
Roswell Park Memorial Institute (RPMI) 
Medium 
Lonza 
Fetal Bovine Serum (FBS) (10%) Lonza 
Penicillin/Streptomycin (1%) Gibco 
Trypan Blue Lonza 
DMSO Fisher-Scientific 
2.1.4 ELISA 
Solutions that are required for IL-10 and IL-17 ELISA studies are given in Table 2.8. 
Table 2.8: Solutions used in IL-10 and IL-17 ELISA experiments. 
Solution Content 
PBS/T 1X 0.05% Tween-20 in PBS 1X 
Stop Solution 2N H2SO4 in ddH2O 
2.1.5 Equipment and Materials 
Laboratory equipments necessary for the study and their  suppliers are shown in Table 2.9 and 
the materials are provided in Table 2.10. 
Table 2.9: Laboratory equipment used in this study. 
Equipment Supplier Company 
Laminar Air Flow Cabinets FASTER BH-EN 2003 
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Table 2.9(cont’d): Laboratory equipment used in this study. 
Equipment Supplier Company 
Laminar Air Flow Cabinets FASTER BH-EN 2003 
 
Centrifuges 
Beckman Coulter Allegra ™ 25 R 
Centrifuge Scanspeed 1730 R 
Labogene Scanspeed mini 
Freezers 
Altus ( + 4°C) 
Siemens ( -20°C) Haier (- 80°C) 
Microplate Spectrophotometer BIO-RAD Benchmark Plus 
Magnetic stirrer 
WiseStir MSH-20D, Wisd Laboratory 
Equipment 
Light Microscope Olympus CH30 
Ice Machine Scotsman AF10 
Flow Cytometer BD Accuri C6 
Nitrogen Tank Air Liquid 
Incubator with CO2 BINDER 
Nanodrop 2000 Thermo Scientific 
Shakers Heidolp Duomax 1030 
Step One Real Time Systems Applied Biosystem 
Sonicator Bandelin Sonopuls 
Vortex Mixer Uzusio VTX-3000L,LMS 
Quick spin LMS 
Scale Precisa 
Table 2.10: Materials used in this study. 
Material Supplier Company 
Tissue flask Sarstedt 
Serologic pipettes Dispenser 
Centrifuge tubes Interlab 
Eppendorf tubes (0.6 ml, 1.5 ml, 2 ml) Interlab 
Nitrocellulose membrane 
(0.2 µm pore size) 
Santa Cruz 
Examination Gloves Beybi 
Cell strainer (70 µm) BD 
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Table 2.10 (cont’d): Materials used in this study. 
Material Supplier Company 
Anaerobic Jar Anaerocult 
Erlens Isolab 
Falcons (15 ml, 50 ml) Isolab 
Slides Interlab 
Coverslips Interlab 
Cotton Swap Interlab 
96 well F plate (for ELISA studies) Nunc 
Hemacytometer Isolab 
Pipettes 
10 µl, 20 µl, 100 µl, 200 µl, 1000 µl 
Socorex and 10 µl, 100 µl, 1000 µl Biohit 
Electronic Pipette CappAid 
Tissue culture flasks (25 cm
2
, 75 cm
2
) Sarstedt 
2.1.6 Commercial kits 
Commercial kits that were used in this study are listed with their supplier companies in the 
table below (Table 2.11). 
Table 2.11: Commercial kits used in this study. 
Kit Supplier Company 
Mouse B Cell Isolation Kit MACS, Miltenyi Biotec 
Mouse Regulatory B cell Isolation Kit MACS, Miltenyi Biotec 
Mouse CD4
+ 
T cell Isolation Kit MACS, Miltenyi Biotec 
NucleoSpin RNA Isolation Kit Macherey-Nagel 
High capacity cDNA syntesis Kit, 
200 rxns 
Applied Biosystems 
Power SYBR® Green PCR Master Mix Applied Biosystems 
Mouse IL-10 ELISA Max Deluxe Biolegend 
Mouse IL-17 ELISA Max Standard Biolegend 
BCA™ Protein Assay Reagent Assay Thermo Scientific 
2.1.7 General chemicals 
General chemicals used in this study are listed with their supplier companies in Table 2.12. 
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Table 2.12: General chemicals used in this study. 
Chemical Supplier Company 
EDTA Applichem 
Ethanol (absolute) Merck 
NaCl Merck 
Glycerol Merck 
Phosphate-Buffered Saline (PBS) 10X Lonza 
Tween-20 Fisher-Scientific 
Bovine Serum Albumin (BSA) Santa Cruz 
DMSO Fisher Scientific 
β-Mercaptoethanol Sigma-Aldrich 
Columbia Agar BD 
Brucella Broth BD 
CampyGen 2.5L Oxoid 
Lipopolysaccharide (LPS) Sigma-Aldrich 
Fixation Buffer (4%) Biolegend 
Permeabilization Buffer 10X Biolegend 
Monensin Calbiochem 
2.1.8 Primers 
Primers that were used in this study are given in Table 2.13. 
Table 2.13: Primers and their sequences used in this study. 
Primer Name Sequence (5‟-3‟) Spec. Tm Exp. size 
IL-17 forward GGACTCTCCACCGCAATGAA m 60°C 94 bp 
IL-17 reverse TTTCCCTCCGCATTGACACA m 60°C 94 bp 
Ror gamma T fw. AGCAATGGAAGTCGTCCTAGTCA m 60°C 110 bp 
Ror gamma T rv. AGCCCAAGGCTCGAAACAG m 60°C 110 bp 
18s rRNA fw. GGCCCTGTAATTGGAATGAGTC m/h 55°C 114bp 
18s rRNA rv. CCAAGATCCAACTACGAGCTT m/h 55°C 114bp 
2.1.9 Antibodies 
Antibodies that were used in this study are given in Table 2.14. 
Table 2.14: Antibodies used in this study. 
Antibody Clone Supplier Company Application 
Recombinant IL-2 - Militenyi Biotech Cell Culture 
Anti-mouse Anti-CD3Ԑ 17A2 Militenyi Biotech Cell Culture 
Rat anti-mouse CD4-APC Rm-4-5 BD FACS 
Rat anti-mouse CD19-FITC 6D5 Biolegend FACS 
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Table 2.14 (cont’d): Antibodies used in this study. 
Antibody Clone Supplier Company Application 
Rat anti-mouse CD62L-APC MEL-14 Biolegend FACS 
Anti-mouse IL-17-FITC TC11-18H10.1 Biolegend FACS 
Rat anti-mouse IL-10-PE JES5-16E3 BD FACS 
Anti-mouse CD25-biotin # 280406 R&D FACS 
Streptavidin-FITC - Biolegend FACS 
Anti-mouse CD49b-FITC DX5 Biolegend FACS 
Anti-mouse LAG-3-PerCpCy5.5 C9B7W Biolegend FACS 
2.2 Methods 
2.2.1 Maintenance of Helicobacter felis 
Helicobacter felis was seeded on a Columbia blood agar containing suitable amounts of the 
antibiotics and incubated at 37°C under microaerophilic conditions in an anaerobic jar for 3-4 
days. Microaerophilic conditions in anaerobic jar were maintained by utilization of 
CampyGen packs. For preparation of Columbia agars, 42,5 g Columbia agar was dissolved in 
1000 ml water. Liquid was autoclaved. The bottle was put in 56 0C water for 1 hour. 
Afterwards, 50 ml horseblood was added to agar. For H. felis growth 10 ml β-cyclodexin and 
1 ml of 1000 X antibiotic cocktail (Table 2.2) was added. After 3-4 days of incubation, the 
bacteria were checked under light microscope for viability and mobility and transferred into 
liquid Brucella Broth containing 10.000 X Vancomycin (final concentration: 1X) with 
necessary dilutions for optimal growth. For preparation of Brucella Broth medium, 28 g of 
brucella broth powder was resuspended in 1L of sterile distilled water (ddH2O). Following 
resuspension, the liquid medium was autoclaved at 121°C for 15 min for sterilization. 
2.2.2 Sonication of H. felis strain 
120-200 ml liquid culture of Helicobacter strains was used for sonication. Before sonication, 
the mobility and viability of Helicobacter felis (10 µl) were checked under light microscope. 
120- 200 ml liquid culture of Helicobacter felis was divided into aliqoutes in 15 ml falcons. 
Falcons were centrifuged at 1500 rpm for 10 minutes. Supernatant was discarded. 10 ml PBS 
was used to wash bacteria. 15 ml falcons were centrifuged at 1500 rpm for 10 minutes. 
Supernatant was discarded. 3.5 ml PBS was added on pellet and mixed. Sonication was 
performed as 30 sec pulse on; 50 sec pulse off for 6.30 minutes at 50 watt on ice to prevent 
excessive heat formation. MS 72 probe of the sonicator was used. Sonicate was aliquoted to 
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as 100 µl for each 0.6 ml eppendorfs. They were centrifuged at 15,000 rpm for 20 minutes at 
4°C. Sonicate concentration was measured with BCA assay. 
2.2.3 Protein bicinchoninic acid (BCA) assay 
For determination of Helicobacter felis sonicates after sonication and determination of protein 
samples after cell lysis, Thermo Scientific‟s Pierce Protein BCA Assay Kit was used. Bovine 
Serum Albumin (BSA) Standard Set was chosen for microassay. According to the total 
number of samples and Bovine Serum Albumin (BSA) standards, working reagent (200 µl per 
sample) was prepared from Solution B and Solution A as 1:50 ratio, respectively and was 
warmed to ambient temperature. 200 µl of working reagent was distributed into each assayed 
well of a 96-well F-bottom plate, and all the samples and standards were used in duplicates in 
order to obtain more accurate results. 10 μl of diluted BSA standards in duplicates were added 
into corresponding working reagent-containing wells with the concentrations of 0,025; 0,125; 
0,25; 0,5; 1; 1,5; 2 mg/mL, respectively. Dilution scheme for BSA standards are given in 
Table 2.15. 10 μl of protein samples (diluted of undiluted) with unknown concentrations were 
added to corresponding working reagent-containing wells, and plate was covered and 
incubated at 37°C for at least 30 min. After 30 min- long incubation, the plate was cooled to 
room temperature and absorbances were measured at 562 nm on microplate reader. 
Table 2.15: Dilution scheme for BCA Assay standards. 
Vial 
Volume of diluents 
ddH2O (µl) 
Volume & source of BSA 
(µL) 
Final BSA 
Concentration (µg/ml) 
A 0 300 of stock 2,000 
B 125 375 of stock 1,500 
C 325 325 of stock 1,000 
D 175 175 of vial B dilution 750 
E 325 325 of vial C dilution 500 
F 325 325 of vial E dilution 250 
G 325 325 of vial F dilution 125 
H 400 100 of vial G dilution 25 
I 400 0 0 = Blank 
2.2.4 Treatment of B cells with Helicobacter felis 
For the separation of Helicobacter-activated-IL10
+
B cells and Helicobacter-activated-IL10
-
B 
cells, purified B cells were treated with H. felis sonicate (10 µg/ml). They were incubated 
with or without H. felis sonicate for 24 hours. After 24 hours long incubation, IL-10 
producing regulatory B cell subset was magnetically labelled and separated from H. felis 
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sonicate-treated cells by using Mouse Regulatory B Cell Isolation Kit (MACS, Miltenyi). The 
procedures for both B cell and regulatory B cell, isolations are explained in detail in 
upcoming sections.  
2.2.5 MACS Mouse B cell isolation 
Splenic B cells were isolated using Mouse B Cell Isolation Kit (MACS Miltenyi). The 
procedure is explained in detail in sections 2.2.5.1-2.2.5.4. 
2.2.5.1 Preparation of the cell suspension 
Spleen obtained from C57BL/6 mouse was put in the center of 70 µm filter mesh carefully by 
the help of a tip. Spleen was meshed on the filter mesh with the plunger of a syringe. Single 
cell suspension was prepared in a 50 ml falcon tube. Incomplete RPMI medium was used to 
soak the filter and rinse cells from filter to the tube. Procedure was repeated for all obtained 
spleens. Tube was filled with incomplete medium. Cell suspension was centrifuged at 1480 
rpm (200g) for 10 minutes. Supernatant was discarded. Cell pellet was dissolved in 1 ml 
MACS buffer per spleen. Cell number was determined. Cells were counted by diluting with 
MACS buffer (~1:200). Cell viability was checked with trypan blue. 
2.2.5.2 Pre-enrichment of B cells 
After cell number and viability was determined, cell suspension was centrifuged at 1780 rpm 
for 8 minutes. Cell pellet was resuspended in 40 µl of MACS buffer per 107 cells. Then 10 µl 
of B Cell Biotin-Antibody Cocktail (containing antibodies targeted against CD4, CD43 and 
Ter-119) was added per 10
7
 cells. Tube was mixed well and incubated at refrigerator for 15 
min. 30 µl of MACS buffer and 20 µl of Anti-Biotin MicroBeads were added per 107 total 
cells. Tube was mixed well and incubated in refrigerator for another 15 min. Cells were 
washed with 1-2 ml of MACS Buffer per 10
7
 cells. Cell pellet was resuspended in 500 µl of 
MACS buffer per 10
8 
cells. 
2.2.5.3 Magnetic separation: depletion of non-B cells 
LS column (if total cell number is less than 2x10
8
 MS column is more suitable for 
purification) was placed in suitable MACS separator (Midi) on magnetic field. Column was 
activated by rinsing with 3 ml of cold MACS buffer. Cell suspension was applied onto the 
column. Column was washed by 3x3 ml of MACS buffer and time was always given for the 
reservoir to be emptied between washing steps. Flowthrough was unlabeled B cells. Column 
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was removed from magnetic field and put in a 15 ml falcon tube. The magnetically labeled 
non-B cells were flushed out with 5 ml of MACS buffer by firmly pushing the plunger of the 
column. Cell number was determined by diluting 1:10 with MACS buffer and cell viability 
was checked with trypan blue under light microscope. Flow cytometer analysis for CD19 
surface marker was performed in order to determine purity of B cells. 
2.2.5.4 Flow staining for CD19 surface marker 
Purity of freshly purified splenic B cells was determined using flow cytometer. 5x10
5
 B cells 
and depleted non-B cells were stained with 0.2 µl FITC conjugated anti- CD19 antibody in 50 
µl FACS Buffer in the dark on ice for at least 45 minutes. A fraction of B and non-B cells 
were left as unstained controls. Then, cells were washed once with 1 ml FACS Buffer by 
centrifugation at 2000 rpm for 5 minutes. Supernatant was discarded and pellet was 
resuspended in 150 µl of FACS Buffer and samples (both unstained and stained) were 
analyzed on flow cytometer. 
2.2.6 IL-10 producing regulatory B cell isolation 
IL-10 producing subset of B cells was magnetically separated by Mouse Regulatory B Cell 
Isolation Kit (MACS Miltenyi). The detailed procedure for isolation of IL-10 producing 
regulatory B cells is explained in sections 2.2.6.1-2.2.6.6. 
2.2.6.1 In vitro stimulation 
Isolated CD19
+
 B cells were centrifuged at 1780 rpm for 8 minutes. Cell pellet was 
resuspended in proper amount of medium (2.5x10
6
 cells/ml). Cells were incubated in 96-well 
U bottom plates with stimulation agent (Helicobacter felis sonicate) for 24 h long incubation 
(Final concentration: 10 µg/ml). Cells which were not stimulated with sonicate were kept as 
control B cells. Yanaba et al. (2009) demonstrated that splenic B cells treated with PMA and 
ionomycin in vitro for 5 hours result in optimal IL-10 production. Therefore, PMA (50 ng/ml) 
and ionomycin (500 ng/ml) were added for the last 5 hours of incubation in order to induce 
IL-10 secretion from Helicobacter-stimulated B cells. 
2.2.6.2 Labeling cells with regulatory B cell catch reagent 
Cells were harvested by collecting into a falcon tube by pipetting up and down. The wells also 
washed with MACS Buffer in order to ensure harvesting of all B cells. Cell number was 
determined by diluting 1:10 with MACS Buffer. For cell viability check, trypan blue staining 
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was performed. Cells were washed by adding MACS buffer and centrifuged at 1780 rpm for 8 
minutes. Supernatant was discarded carefully. Cell pellet was resuspended in 90 µl of cold 
medium per 10
7
 total cells. 10 µl of Regulatory B Cell Catch Reagent was added per 107 total 
cells. Regulatory B Cell Catch Reagent is a specific molecule which has two binding domains 
one of which recognizes CD45 on B lymphocytes and the other recognizing IL-10. Tube was 
mixed well and incubated on ice for 5 min. 
2.2.6.3 IL-10 secretion period 
10 ml warm medium was added per 10
7
 cells. Cells were incubated in closed tube for 45 min 
at 37°C. Tube was turned upside down every 5 minutes to resuspend settled cells. In this 
period, the aim was basically to catch IL-10 secreted from Helicobacter-stimulated B cells on 
cell surface following binding of catch reagent to CD45 surface marker on B cells. 
2.2.6.4 Labeling cells with regulatory B cell detection antibody (PE) 
The tube was filled with cold MACS buffer. The tube was incubated on ice for 5 min. in order 
to prevent non-specific antibody binding. Cells were centrifuged at 1780 rpm for 8 minutes. 
Supernatant was discarded carefully. Cell pellet was resuspended in 90 µl of MACS buffer 
per 10
7
 total cells. A fraction of unlabeled cells were separated as unstained control. 10 µl of 
Regulatory B Cell Detection Antibody (PE) was added per 10
7
 total cells. Tube was mixed 
well and incubated for 15 min on ice. In this step, IL-10 which was secreted from 
Helicobacter-stimulated B cells and caught on cell surface via catch reagent was labeled by a 
PE-conjugated IL- 10 detection antibody. 10 ml of cold MACS buffer was added for washing 
and the tube was centrifuged at 1780 rpm for 8 minutes. Supernatant was discarded carefully. 
2.2.6.5 Magnetic labeling with anti-PE microbeads 
Cell pellet was resuspended in 80 µl of cold buffer per 107 total cells. 20 µl of Anti- PE 
MicroBeads were added per 10
7
 total cells. Tube was mixed well and incubated for 15 min in 
the refrigerator. This step enabled magnetic labeling of IL-10 producing Helicobacter-
activated B cells by anti-PE Microbeads which is bound to PE-conjugated IL-10 detection 
antibody. Cells were washed by adding 10 ml of cold MACS buffer per 10
7
 total cells. Tube 
was centrifuged at 1780 rpm for 8 minutes. Supernatant was discarded carefully. Cell pellet 
was resuspended in 500 µl of cold MACS buffer (up to 5x107 cells, the working dilution was 
10
8
 cells/ml for higher cell numbers). 
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2.2.6.6 Magnetic separation using MS column 
MS column (up to 2x10
8
 total cells) was placed on mini MACS Separator in the magnetic 
field. Column was activated by rinsing with the 500 µl of MACS buffer. Cell suspension was 
applied onto the column. Unlabeled cells (IL-10 negative B cell fraction) were collected as 
flow-through and column was washed 3 times with 500 µl MACS buffer. Column was 
removed from separator and put on a falcon tube. 1 ml of MACS buffer was pipetted onto the 
column and magnetically labeled cells (IL-10 positive B cell fraction) were flushed out by 
plunger. Cell numbers were determined by diluting 1:10 with MACS buffer and cell viability 
was checked with trypan blue under light microscope. Flow cytometer analysis was 
performed for IL-10-PE in order to check the purity of IL-10 positive and IL-10 negative 
fractions. A fraction of B+H.f. cells before addition of PE-coupled IL-10 detection antibody 
was separated as unstained control. The steps of procedures including splenic murine CD19
+
 
B cell isolation and separation of B cells according to their IL-10 production capacity 
following stimulation with H. felis sonicate for 24 hours are displayed in Figure 2.1. 
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Figure 2.1: Purification of murine splenic B cells and subsequent separation of B cells according to 
their IL-10-production capacities. CD19
+
 B cells were purified from murine splenic cells (splenocytes) 
by negative selection (Macs Miltenyi). All splenocytes except for CD19
+
 cells were magnetically 
labeled by an antibody cocktail and CD19
+
 B cells were acquired as flow through in a magnetic field. 
Purified B cells were cultured (2,5x10
6
 cells/ml) in the presence of H.felis sonicate (10µg/ml) for 24 h. 
PMA (50 ng/ml) and ionomycin (500 ng/ml) were added into the culture  during the last 5 h in order  
to induce IL-10 secretion. Following 24 h-long incubation, cells were harvested and labeled with a 
compound called Regulatory B Cell Catch Reagent (Macs Miltenyi) that was designed to capture 
secreted IL-10 at IL-10 secretion period on the cell surface. Then, cells were magnetically labeled with 
an PE- conjugated IL-10 detection antibody. Upon application of a magnetic field, IL-10 producing B 
cells (IL-10
+ 
B) were kept in the column (Macs Miltenyi) whereas IL-10 negative B cells (IL-10
-
B) 
were acquired as flow-through. IL-10
+ 
B cells were obtained by subsequent flushing-out of cells from 
the column. 
2.2.7 MACS Mouse CD4
+
T cell isolation 
CD4
+
 T cells were isolated using Mouse CD4
+
 T Cell Isolation Kit (MACS Miltenyi). The 
procedure is explained in detail in sections 2.2.6.1-2.2.6.4. 
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2.2.7.1 Preparation of the cell suspension 
Spleen obtained from C57BL/6 mouse was put in the center of 70 µm filter mesh carefully by 
the help of a tip. Spleen was meshed on the filter mesh with the plunger of a syringe. Single 
cell suspension of the spleen was prepared in a 50 ml falcon tube. Incomplete RPMI medium 
was used to soak filter and rinse cells from filter to the tube. Procedure was repeated for all 
obtained spleens. Tube was filled with incomplete medium. Cell suspension was centrifuged 
at 1480 rpm (200g) for 10 minutes. Supernatant was discarded. Cell pellet was dissolved in 1 
ml MACS buffer per spleen. Cell number was determined. Cells were counted by diluting 
with MACS buffer (~1:200). Cell viability was checked with trypan blue. 
2.2.7.2 Magnetic labeling of non-CD4+ T cells 
After cell number and viability was determined, cell suspension was centrifuged at 1780 rpm 
for 8 minutes. Cell pellet was resuspended in 40 µl of MACS buffer per 107 cells. Then 10 µl 
of T Cell Biotin-Antibody Cocktail (containing antibodies targeted against CD8a, CD11b, 
CD11c, CD19, CD45 (B220), CD49b (DX5), CD105, anti-MHC Class II, Ter-119, TCRƔ/δ) 
was added per 10
7 cells. Tube was mixed well and incubated at refrigerator for 5 min. 30 µl of 
MACS buffer and 20 µl of Anti-Biotin MicroBeads were added per 107 total cells. Tube was 
mixed well and incubated in refrigerator for another 10 min. Cells were washed with 1-2 ml 
of MACS Buffer per 10
7
 cells. Cell pellet was resuspended in 500 µl of MACS buffer per 108 
cells. 
2.2.7.3 Magnetic separation: depletion of non-T cells 
LS column (if total cell number is less than 2x10
8
 MS column is more suitable for 
purification) was placed in suitable MACS separator (Midi) on magnetic field. Column was 
activated by rinsing with 3 ml of cold MACS buffer. Cell suspension was applied onto the 
column. Column was washed by 3x3 ml of MACS buffer and time was always given for the 
reservoir to be emptied between washing steps. Flowthrough was unlabeled T cells. Column 
was removed from magnetic field and put in a 15 ml falcon tube. The magnetically labeled 
non-T cells were flushed out with 5 ml of MACS buffer by firmly pushing the plunger of the 
column. Cell number was determined by diluting 1:10 with MACS buffer and cell viability 
was checked with trypan blue under light microscope. Flow cytometer analysis for CD4 
surface marker was performed in order to determine purity of T cells. 
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2.2.7.4 Flow staining for CD4 surface marker 
Purity of freshly purified splenic T cells was determined using flow cytometer. 5x10
5
 T cells 
and depleted non-T cells were stained with 0.2 µl APC conjugated anti- CD4 antibody in 50 
µl FACS Buffer in the dark on ice for at least 45 minutes. A fraction of T and non-T cells 
were left as unstained controls. Then, cells were washed once with 1 ml FACS Buffer by 
centrifugation at 2000 rpm for 5 minutes.Supernatant was discarded and pellet was 
resuspended in 150 µl of FACS Buffer and samples (both unstained and stained) were 
analyzed on flow cytometer. 
2.2.8 Co-culture of Helicobacter-activated-B cells and T cells 
To observe the interaction between the Helicobacter-activated-B cell subgroups and CD4
+
 T 
cells, isolated CD4
+ 
T cells were put on co-culture in 1:1 ratio with the Helicobacter-
activated-IL-10
+
 B cells and Helicobacter-activated-IL-10
-
 B cells (separation is explained in 
section 2.2.6) for 24 hours.  
2.2.9 Antibody stainings for flow cytometry 
2.2.9.1 Surface marker stainings 
After 24 hour incubation (37°C, 5% CO2) of the co-cultures of B and T cells, the cells were 
harvested, centrifuged at 2000 rpm for 5 minutes, resuspended in FACS Buffer and separated 
into 0,5 ml eppendorf tubes for different stainings. One sample for each different co-culture 
group was left as unstained control. Cells were re-suspended in 50 µl of 2% FACS buffer, 
antibodies for surface stainings are added into the tubes with appropriate concentrations. Cells 
were incubated for 1 hour at 4°C for staining. Afterwards, cells were washed with 2% FACS 
buffer and centrifuged at 2000 rpm for 5 minutes. Supernatants were discarded and the pellets 
were resuspended in 150 µl of 2% FACS buffer for flow cytometry analysis. 
2.2.9.2 Intracellular stainings for IL-10 and IL-17 
For in vitro stimulation of cells, it is necessary to block secretion of cytokines with protein 
transport inhibitors, such as the Monensin or Brefeldin A Solution. In order to determine 
intracellular IL-10 and IL-17 production levels via flow cytometry, the IL-10 and IL-17 
cytokine secretion was blocked by Monensin (3μg/ml, Calbiochem) 5 hours before harvesting 
of the cells. Monensin is a protein transport inhibitor commonly used to enhance intracellular 
cytokine staining signals by blocking transport processes during cell activation. It leads to the 
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accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (Jung et al., 
1993). A fraction of the co-culture cells were left as unstained controls. After harvesting of 
the cells by centrifugation at 2000 rpm for 5 minutes, cells were fixed with 100 µl of 2% 
Fixation Buffer (Biolegend) containing paraformaldehyde that cross-links the proteins, for 15 
minutes on ice. Following fixation, cells were washed with 500 µl of FACS Buffer once by 
centrifugation at 2000 rpm for 5 minutes. Supernatant was discarded and pellets were 
resuspended in 175 µl of 1X Permeabilization Buffer (diluted from 10X with ddH2O) to 
provide access to intracellular antigens. Saponin in the permeabilization buffer interacts with 
membrane cholesterol, selectively removing it and leaving holes in the membrane. Cells were 
centrifuged at 2000 rpm for 5 minutes. Pellets were resuspended in 175 µl of 1X 
Permeabilization Buffer once more, then they were centrifuged at 2000 rpm for 5 minutes. 
This results in the creation of pores in the cellular membrane that require the continuous 
presence of the permeabilization buffer during all subsequent steps to allow antibodies to have 
access to the cytoplasm of the cell.  The cells are resuspended in 50 µl of permeabilization 
buffer containing  0.4 µl of PE-coupled anti-mouse IL-10 detection antibody (MACS 
Miltenyi) and 0.4 µl of FITC-coupled anti-mouse IL-17 detection antibody (MACS Miltenyi). 
Afterwards, samples were stained in the dark at 4°C for more than 1 hour. Following the 
incubation, cells were washed with 175 µl permeabilization buffer by centrifugation. Pellets 
were washed once in 500 µl of FACS Buffer by centrifugation and pellets were resuspended 
in 150 µl of FACS Buffer and analyzed on flow cytometer. 
2.2.10 ELISA  
2.2.10.1 IL-10 ELISA 
IL-10 protein levels in supernatant of samples were determined by Biolegend‟s Mouse IL-10 
ELISA Deluxe Max Kit. For quantitative determination of IL-10 protein in culture medium of 
B cells, Nunc 96-well plates were coated with IL-10 capture antibody 1:200 diluted in coating 
buffer 1X and plate was incubated at 4°C overnight. Following day, plate was washed four 
times with PBS/T. Then, 100 µl of Assay Diluent A 1X (diluted from 5X with PBS 1X) was 
added into assayed wells and the plate was incubated at room temperature for 1h. 
Recombinant IL-10 standards were prepared by serial dilution according to manufacturer‟s 
instructions. After that, plate was again washed four times with PBS/T. Following washing 
steps, diluted recombinant IL-10 standards and culture media supernatants (50 µl) were added 
as biological duplicates. Plate was incubated at room temperature for 2 h. Following 2 h-long 
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incubation, plate was washed four times with PBS/T. Biotinylated IL-10 detection antibody 
diluted 1:200 in Assay Diluent 1X was added into each assayed well and plate was incubated 
at room temperature for 1 h. After washing of assayed wells with PBS/T for three times, 
Avidin-HRP solution 1:1000 diluted in Assay Diluent A 1X was added into each assayed well 
as 50 µl and plate was incubated in the  dark for 30 min at room temperature. After 30 min-
long incubation, plate was washed for five times with PBS/T and 50 µl of TMB Substrate 
Solution Mixture (1:1 of TMB Substrate A and TMB Substrate B) was added into each 
assayed well. The plate was incubated for at least 30 minutes at room temperature. High 
concentration standards and samples turned into blue. After that, the reaction was stopped 
with 50 µl stop solution (2N H2SO4). Then, the absorbances of the samples were measured at 
450 nm on a microplate reader. 
2.2.10.2 IL-17 ELISA 
IL-17 protein levels in supernatant of samples were determined by Biolegend‟s Mouse IL-17 
ELISA Kit. For quantitative determination of IL-17 protein in culture medium of B and T 
cells, Nunc 96-well plates were coated with IL-17 capture antibody 1:200 diluted in coating 
buffer 1X and plate was incubated at 4°C overnight. Following day, plate was washed four 
times with PBS/T. Then, 100 µl of Assay Diluent A 1X (diluted from 5X with PBS 1X) was 
added into assayed wells and the plate was incubated at room temperature for 1h. 
Recombinant IL-17 standards were prepared by serial dilution according to manufacturer‟s 
instructions. After that, plate was again washed four times with PBS/T. Following washing 
steps, diluted recombinant IL-17 standards and culture media supernatants (50 µl) were added 
as biological duplicates. Plate was incubated at room temperature for 2 h. Following 2 h-long 
incubation, plate was washed four times with PBS/T. Biotinylated IL-17 detection antibody 
diluted 1:200 in Assay Diluent 1X was added into each assayed well and plate was incubated 
at room temperature for 1 h. After washing of assayed wells with PBS/T for three times, 
Avidin-HRP solution 1:1000 diluted in Assay Diluent A 1X was added into each assayed well 
as 50 µl and plate was incubated in the  dark for 30 min at room temperature. After 30 min-
long incubation, plate was washed for five times with PBS/T and 50 µl of TMB Substrate 
Solution Mixture (1:1 of TMB Substrate A and TMB Substrate B) was added into each 
assayed well. The plate was incubated for at least 30 minutes at room temperature. High 
concentration standards and samples turned into blue. After that, the reaction was stopped 
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with 50 µl stop solution (2N H2SO4). Then, the absorbances of the samples were measured at 
450 nm on a microplate reader.  
2.2.11 Analysis of relative expression levels 
2.2.11.1 RNA isolation 
To determine relative expression levels of IL-10 and IL-17, T cell, B cell and T&B co-culture 
pellets were subjected to RNA isolation. To lyse the cells, 350 µl of RA1 lysis buffer and 3.5 
μL ß-mercaptoethanol were added to cell pellets and then they were vortexed vigorously. For 
the filtration of the lysates, NucleoSpin® Filter was placed in a Collection Tube (2 mL) and 
the mixture is applied on the filter, then centrifuged for 1 min at 11,000 x g. The 
NucleoSpin® Filter is discarded. 350 µl of 70% ethanol was added to flowthrough and the 
solution is homogenized by pipetting up and down at least 5 times. After homogenization, 
lysates are loaded on the NucleoSpin® RNA Column (blue ring) and centrifuged at 11,000 x 
g for 30 seconds. To digest the DNA, DNase reaction mixture is prepared in a sterile 1,5 mL 
eppendorf tube. For each isolation, 10 μL reconstituted  rDNase was added to 90 μL Reaction 
Buffer for rDNase. The solution was mixed by flicking the tube. 95 μL DNase reaction 
mixture was directly applied onto the center of the silica membrane of the column. The tubes 
are incubated at room temperature for 15 minutes. To inactivate the rDNase, 200 μL Buffer 
RAW2 was added to the NucleoSpin® RNA Column. Tubes were centrifuge for 30 s at 
11,000 x g. The column was placed into a new Collection Tube (2 mL). For efficient washing 
of the inner rim, 600 μL Buffer RA3 was added to the NucleoSpin® RNA Column. The tubes 
were centrifuge for 30 s at 11,000 x g.  The flowthrough was discarded and the column was 
placed back into the Collection Tube. For a final washing, 250 μL Buffer RA3was added to 
the NucleoSpin® RNA Column, centrifuged for 2 min at 11,000 x g to dry the membrane 
completely. Then the column was placed into a nuclease-free Collection Tube (1.5 mL). 35 µl 
of RNAse-free water was added on filter and incubated for 1 min at room temperature. 
Finally, tubes were centrifuged at 11,000 x g for 1 min. Flow through was kept as isolated 
RNA. The RNA concentrations were measured with NanoDrop. 
2.2.11.2 cDNA synthesis 
Synthesis of cDNA was performed according to manufacturer‟s instructions. Amounts used in 
synthesis reaction are given in Table 2.16. Synthesis conditions are given in Table 2.17. 
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Table 2.16: Components of cDNA synthesis reaction. 
Component Amount 
RNA (1µg) depends on concentration 
ddH20 15.075 µl – amount of RNA 
10 X RT Buffer 2 µL 
Oligo dT (10µM) 1 µl 
Ribolock Rnase Inh. 0.125 µl 
Reverse Transcriptase 1 µl 
25 X dNTP mix 0.8 µl 
Table 2.17: Reaction conditions of cDNA synthesis. 
Temperature Time 
25°C 10 min. 
37°C 120 min 
85°C 5 min. 
4°C ∞ 
2.2.11.3 Real time PCR 
Relative expression levels of IL-17 and Ror gamma T was analyzed with Real - time PCR. 
Amounts used in reaction are given in Table 2.18. PCR conditions performed are given in 
Table 2.19. 
Table 2.18: PCR reaction components. 
Component Amount 
Power Sybr Master Mix (2X) 5 µl 
Frw Primer (10 µM) 0.5 µl 
Rev Primer (10 µM) 0.5 µl 
PCR Grade water 1.5 µl 
Table 2.19: Reaction conditions of real time PCR. 
Temperature Time 
95°C 5 min. 
95°C 30 sec. 
1 min. 
(45 cycles) 
Depends on primer 
2°C 1 min. 
72°C 5 min. 
4°C ∞ 
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2.2.12 Flow cytometry analyses 
Flow cytometry analyses were performed using FlowJo and Accuri C6 software. 
2.2.13 Statistical analyses 
All p values were calculated using GraphPad Prism 6.0 software. Significancies were 
determined by Student t test. In all analyses, a two-tailed p-value of less than 0.05 was 
considered statistically significant. In column bar graphs, vertical bars indicate standard 
deviations of the mean, n.d. stands for not determined, and n.s. denotes not significant. 
 
 
 
53 
3.  RESULTS 
3.1 CD19+ B cell isolation from spleens of C57BL/6 mice 
B cells were isolated from spleens of C57BL/6 mice by using B Cell Isolation Kit 
(see Materials&Methods, Section 2.2.5). Pre- enrichment of B cells was performed 
by negative selection using magnetic separation method. Following the separation, to 
detect their purity, B cells were labeled with FITC-coupled anti-CD19 antibody and 
compared to unstained control. Flow cytometry analyses showed that the B cells 
were isolated with purities higher than 83% with an average purity of almost 90% 
(Figure 3.1).  
A)                                                                     C) 
                                                                                           
 
 
 
 
 
 
 
 
  B)   
 
 
 
 
 
 
 
 
 
Figure 3.1: Purity of B cells isolated from spleen of C57BL/6. Representative flow cytometry quadrant plot (A)  
and histogram plot (B) of purified B cells compared to unstained control. B cells were magnetically isolated from 
spleen of C57BL/6 mice by negative selection. Cells were either stained with FITC-coupled anti-CD19 antibody 
(0.5 µg/µl) or left unstained (unstained control) in order to detect the percentage of cells expressing B cell- 
specific surface marker CD19. (C) B cell purities of each experiment and a mean value are shown in the graph. 
For the measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo Software is used. Graphs are 
prepared with Graphpad Prism 6 software. 
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3.2 Separation of Helicobacter-activated-IL-10+ B cells and Helicobacter-
activated-IL-10
-
 B cells 
To obtain IL-10-producing B cells upon Helicobacter felis sonicate activation, after 
24 hours of H.felis stimulation, B cells were subjected to magnetic separation 
(see Materials&Methods, Section 2.2.6). The basis of the separation is to capture 
secreted IL-10 on the surface of IL-10 secreting B cells with an anti-IL-10-PE 
antibody. Thus, after magnetic separation of the IL-10
+ 
and IL-10
-
 B cells, the purity of 
the cells is determined by assessing the intensity of PE fluorochrome (Figure 3.2).   
               A) 
 
 
 
 
             B) 
 
 
 
 
               C)  
 
 
 
 
 
Figure 3.2: Percentages of IL-10 positive and IL-10 negative B cells after Helicobacter felis treatment for 24 
hours. Representative flow cytometry quandrat plot (A) and histogram plot (B) of separated Helicobacter-
activated IL-10+ and IL-10- B cells compared to unstained control. (C)IL-10+ and IL-10- B cell purities of all 
experiments and a mean value are shown in the graph. For the measurements BD ACCURI C6 flow cytometer 
and for the analyses FlowJo Software was used. Graphs were prepared with Graphpad Prism 6 software. 
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3.3 CD4+ T cell isolation from C57BL/6 mice 
Splenic CD4
+
 T cells magnetically isolated with CD4
+ 
T Cell Isolation Kit (MACS, 
Militenyi) from C57BL/6 mice (see Materials&Methods, Section 2.2.6). Negatively 
selected CD4
+
 T cell fractions were collected. Following the separation, CD4
+
 T cells 
were labeled with APC-coupled anti-CD4 antibody and compared to unstained 
control. Flow cytometer analysis was performed to measure the purity (Figure 3.3).  
    A) 
  
 
 
 
 
  B) 
 
 
 
 
 
                  C)   
 
 
  
 
 
Figure 3.3: Purity of CD4+T cells isolated from C57BL/6 mice. Representative flow cytometry quadrant plot (A)  
and histogram plot (B) of purified CD4+T cells compared to unstained control. CD4+T cells were magnetically 
isolated from spleen of C57BL/6 mice by negative selection. Cells were either stained with APC-coupled anti-
CD4 antibody (0.5 µg/µl) or left unstained (unstained control) in order to detect the percentage of cells expressing 
CD4+T cell- specific surface marker CD4. (C) CD4+T cell purities of all experiments and a mean value is shown 
in the graph. For the measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo Software was 
used. Graphs were prepared with Graphpad Prism 6 software. 
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Addition to CD4, another surface marker, CD25, was labeled to observe the activated 
T cell ratio in the CD4
+
 T cell population. CD25 is the alpha chain of the IL-2 
receptor. It is a type I transmembrane protein present on activated T cells. CD25 has 
been also used as a marker to identify CD4
+
FoxP3
+
 regulatory T cells in mice. Right 
after the T cell isolation, a surface antibody staining was applied with FITC coupled 
anti-CD25 antibody and APC coupled anti-CD4 antibody (Figure 3.4). 
A)  
 
 
 
 
 
 
B)    
 
                                                                      
 
 
 
 
 
 
 
 
 
Figure 3.4: CD25 levels of freshly isolated CD4
+
T cells. (A) Representative flow cytometry plot of 
CD25 and CD4 surface stainings of CD4
+
T cells compared to unstained control. Directly after 
isolation of CD4
+
T cells, cells were stained both with APC-coupled anti-CD4 antibody (0.5 µg/µl) 
and FITC coupled anti-CD25 antibody or left unstained (unstained control). (B) CD4
+
CD25
+
 T cell 
percentages of all experiments and a mean value is shown in the graph (4 experiments). For the 
measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo Software is used. Graphs 
are prepared with Graphpad Prism 6 software. 
To sum up, CD19
+
 B cells as well as CD4
+
 T cells were isolated with high purities, 
while the level of CD4
+
CD25
+
 T cells were low. After 24 hour treatment of B cells 
with Helicobacter felis, the Helicobacter-activated-IL-10
+
 B cells ( HACT-IL-10
+
 B) 
and Helicobacter-activated-IL-10
-
 B ( HACT -IL-10
-
 B) cells were successfully 
separated with purities higher than 80% and 90% respectively. 
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3.4 Effects of HACT-IL-10
+
 B cells and HACT -IL-10
-
 B cells on Tr1 cell 
differentiation 
By using mouse models of Helicobacter-induced gastric pathology, Sayı et al. 
showed regulatory function of B cells depended on their ability to sense and respond 
to Helicobacter TLR-2 ligand and to directly interact with naive T cells, which are 
converted to Tr-1–like, CD4+CD25+IL-10+ cells in a CD40L- and CD28-dependent 
manner (Sayi et al., 2011). Based on this information, it was known that 
Helicobacter-activated B cells could differentiate T cells to Tr1 cells; however, it 
was not clear which subset of these Helicobacter-activated B cells took part in this 
differentiation. For this reason, after the separation of HACT-IL-10
+
 B cells and HACT -
IL-10
-
 B cells, CD4
+ 
T cells were placed into co-culture with these Helicobacter-
activated B cell subsets. They were cultured in 1:1 ratio, for 24 hour (37°C, 5% 
CO2). As a control group, only T cell group without B cells were included in the 
experiments.  
3.4.1 IL-10 levels of CD4
+
 T cells in co-culture with HACT-IL-10
+
 B cells and 
HACT -IL-10
-
 B cells 
The IL-10 production of CD4
+
T cells was examined by intracellular IL-10 antibody 
staining which was afterwards detected by flow cytometry (Figure 3.5). For this 
purpose, the cells in the co-cultures were treated with a protein transport inhibitor, 
Monensin (3μg/ml, Calbiochem) to keep the cytokines accumulated inside the Golgi 
complex. T cells were labeled with APC-coupled anti-CD4 antibody. Secondly, the 
cells were fixed with 2% fixation buffer which contains paraformaldehyde that cross-
links proteins. Next, by using a saponin-based Permeabilization Buffer (Biolegend), 
holes were created in the membrane thereby allowing the intracellular staining 
antibodies to enter the cell effectively. After the cells were permeabilized, they were 
incubated with PE-coupled anti-IL-10 antibody that was prepared inside the 
permeabilization buffer. 
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Figure 3.5: IL-10 Levels of CD4+ T cells co-cultured with Helicobacter-activated IL-10+B and IL-10-B cells. 
Representative flow cytometry quadrant plot (A) and a histogram plot (B)  of CD4+IL-10+ T cells in co-culture 
with B cell subsets compared to unstained control is given. Cells were stained with anti-CD4-APC and 
intracellular staining was done for IL-10 cytokine using anti-IL10-PE antibody. To detect the IL-10 levels for T 
cells were shown in , CD4gate. (C) A graphical expression of the CD4+IL-10+ T cells within the co-culture groups 
(4 independent experiments). For the measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo 
Software was used. Graphs were prepared with Graphpad Prism 6 software. Significancy evaluation was 
performed with Student‟s t test (p<0.05 was significant). 
A) 
 
B) 
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As shown in Figure 3.5, when compared with only T cell groups, both co-culture 
groups had significantly higher levels of IL-10 producing T cells. About 15% of T 
cells co-cultured with HACT-IL-10
+
 B cells produced IL-10 while almost 20% of the T 
cell population was IL-10 positive when T cells were co-cultured with HACT-IL-10
-
 B 
cells. Even though there were some deviations within the four experimental data sets 
that led to relatively high standard deviations in the result graph (Figure 3.5(C)), the 
IL-10 cytokine production levels of T cells in two co-culture groups were 
comparable for all experiments. Altogether, it could be suggested that in both co-
culture groups there was a significant differentiation of CD4
+
 T cells into IL10
+
CD4
+
 
Tr1-like cells. 
3.4.2 IL-10 secretion levels in co-culture groups of T cell with HACT-IL-10
+
 B 
cells and HACT -IL-10
-
 B cells 
To proceed the intracellular staining of IL-10, the cells were treated with Monensin 
for the cytokine accumulation inside the cells for 5 hours; however the overall IL-10 
which was secreted out of the cells could not be measured by that method. For a 
better understanding of the amount of secreted IL-10 levels from the co-cultures, IL-
10 ELISA was performed with the 24 hour co-culture supernatants (Figure 3.6). 
 
Figure 3.6: IL-10 Secretion Levels in co-culture groups of CD4
+
 T cells with Helicobacter-
activated IL-10
+
B and IL-10
- 
B cells. CD4
+
 T cells were either co-cultured with 
Helicobacter-activated IL-10
+ 
B and IL-10
- 
B cells or left alone. Supernatants were collected 
after 24 hour co-culture and the amounts of secreted IL-10 were measured with IL-10 
ELISA. Bar graph was prepared with GraphPad Prism 6 software. 
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According to IL-10 ELISA results, CD4
+
T cells co-cultured with IL-10
+
B cells and 
IL-10
-
B cells secreted twice IL-10 when compared to only T cells. For IL-10
+
B cell 
and T cell co-culture, a part of secreted IL-10 came from B cells while all the IL
-
10 
secreted from IL-10
-
B cell and T cell co-culture originated from T cells. All in all, it 
is suggested that compared to IL-10
+
B cells, IL-10
-
B cells drive more IL-10 secretion 
from CD4
+
T cells. 
3.4.3 CD25 expression levels of CD4
+
 T cells in co-culture with HACT-IL-10
+
 B 
cells and HACT -IL-10
-
 B cells 
Following the activation of T cells, CD25 is expressed on these cells and IL-2 is 
immediately synthesized (Kuniyasu et al., 2000). In addition, it is known to be 
expressed by regulatory T cell types (natural Tregs and CD4
+
CD25
+
Foxp3
+
 induced 
Tregs) (Sakaguchi et al., 2006).  After the isolation of CD4
+
 T cells from mice 
spleens, these cells express low levels of CD25. The comparison of the CD25 levels 
after T cells were cultured with Helicobacter-activated B cell subgroups would give 
an opinion whether the T cell activation could alternate when co-cultured with 
different subgroups of Helicobacter-activated B cells. Therefore, after 24 hours of 
co-culture, anti-CD4-APC and anti-CD25-FITC antibodies were used for the labeling 
of those surface markers and analyzed by flow cytometry. 
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Figure 3.7: Increase in CD25 levels in CD4+ T cells co-cultured with Helicobacter-activated IL-10+B and IL-10- 
B cells. Representative flow cytometry quadrant plot (A) and histogram plot (B) of CD25+CD4+T cells in co-
culture groups compared to unstained control. Cells were labeled with anti-CD4-APC and anti-CD25-FITC and 
to see the CD25 levels only for T cells, a CD4 gate was selected. (C) A graphical expression of the CD25+CD4+ T 
cells within the co-culture groups (4 experiments). For the measurements BD ACCURI C6 flow cytometer and 
for the analyses FlowJo Software was used. Graphs were prepared with Graphpad Prism 6 software. Significancy 
evaluation was performed with Student‟s t test (p<0.05 was significant). 
A) 
C) 
B) 
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As shown by Thornton et al. (1998) CD4
+
CD25
+
 T cells expanded when they were 
cultured with anti-CD3 and IL-2. Being consistent with this knowledge, in only T 
cell groups, when compared to the CD25 levels in freshly isolated T cells, an 
increase in CD25 positive T cells was observed after 24 hour incubation (compared 
with the results from Figure 3.4). Furthermore, the increase in CD25 expression in 
co-culture groups could be explained in two ways: the increased activation of T cells 
or the induction of T cells to differentiate into other regulatory T cell subtypes. Even 
though these results need further experiments to reveal the reason behind the increase 
in CD25 expression on T cells, they indicated a significant difference in the CD25 
expression in T cell co-cultures with IL-10
-
B cells compared  to the T and IL-10
+
B 
cell co-cultures.  
3.4.4 CD62L expression levels of CD4
+
 T cells in co-culture with HACT-IL-10
+
 B 
cells and HACT -IL-10
-
 B cells 
CD62L, also known as L-selectin, is a 74-95 kD glycoprotein which is expressed on 
the majority of B and naïve T cells, and a subset of memory T cells. It is rapidly shed 
from lymphocytes upon cellular activation (Gerberick et al., 1997). Therefore, the 
expression levels of CD62L in conjunction with other markers have been used to 
distinguish naïve, effector, and memory T cells. The anti-CD62L antibody is also 
coupled with APC as anti-CD4 antibody. Consequently, the staining was done with 
anti-CD62L-APC and anti-CD19-FITC antibodies. To observe the CD62L levels in 
CD4
+
 T cells, anti-CD19-FITC negative gate was selected (Figure 3.8).   
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Figure 3.8: CD62L Levels of CD4+ T cells co-cultured with Helicobacter-activated IL-10+B and IL-10- B cells. 
Representative flow cytometry quadrant plot (A) and histogram plot (B) of anti-CD62L-APC and anti-CD19-
FITC staining. Since the B cells were labeled with anti-CD19 antibody, a negative gate to CD19 was selected to 
see the CD62L levels in T cells. (B) CD19-CD62L+ cell ratios for co-culture groups are represantatively shown 
on histogram. (C) A graphical expression of the CD4+CD62L+ T cells within the co-culture groups. For the 
measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo Software was used. Graphs were 
prepared with Graphpad Prism 6 software. 
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T-cell activation provokes the shedding of CD62L from the membrane (Mascarell et 
al., 2004). Together with increased CD25 levels (Result 3.4.3), the significant 
difference in CD62L expression on T cells suggest that T cells interacting with 
Helicobacter-activated IL-10
-
B cells show higher activation compared to the co-
culture group with  Helicobacter-activated IL-10
+
B cells.  
3.4.5 CD49b-LAG3 co-expression levels of CD4
+
 T cells in co-culture with HACT-
IL-10
+
 B cells and HACT -IL-10
-
 B cells 
Sayı et. al showed that B cells which were activated by Helicobacter induce IL-10–
producing CD4
+
CD25
+
 Tr1–like cells in vitro. According to their results, it was 
suggested that B cell-induced Tr-1 cells acquire suppressive activity both  in vitro 
and in vivo (Sayi et al., 2011). In addition, Gagliani and collegues identified that the 
coexpression of CD49b and LAG-3 distinguishes Tr1 cells from Th1, Th2 and Th17 
cells (Gagliani et al., 2013). Based on this information, CD4
+
 T cells cultured with 
HACT-IL-10
+
 B cells and HACT -IL-10
-
 B cells were examined for their LAG-3 and 
CD49b co-expressions by flow cytometry (Figure 3.9). 
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Figure 3.9: LAG3-CD49b co-expression levels of CD4
+ 
T cells co-cultured with Helicobacter-
activated IL-10
+
B and IL-10
-
 B cells. (A) Representative flow cytometry plot of  
LAG3
+
CD49b
+
CD4
+
T cells compared to unstained control. Cells were labeled with anti-CD4-APC, 
anti-LAG3-PerCpCy5.5 and CD49b-FITC. To see the co-expression levels only for T cells, a CD4 
gate was selected. B) A graphical expression of the LAG3
+
CD49b
+
CD4
+ 
T cells within the co-culture 
groups. For the measurements BD ACCURI C6 flow cytometer and for the analyses FlowJo Software 
was used. Graphs were prepared with Graphpad Prism 6 software. Significancy evaluation was 
performed with Student‟s t test (p<0.05 was significant). 
B) 
A) 
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Flow cytometry results of CD4-CD49b-LAG3 stainings showed that  almost 20% of  
T cells co-cultured with IL-10
+
B cells express those three surface markers while only 
around 10% of CD4
+
 T cells co-cultured with IL-10
-
B cells express CD49b and 
LAG3 together. According to those results, it could be suggested that CD4
+
 T cells 
differentiate into Tr1-like cells when co-cultured with both of the Helicobacter-
activated B cell subgroups; however, IL-10
+
B cells seemed to have more potency on 
CD49b-LAG3 co-expression on CD4
+
 T cell surfaces. 
3.5 Effects of HACT-IL-10
+
 B cells and HACT -IL-10
-
 B cells in Th17 cell 
differentiation 
CD4
+
 T cells obtain distinct functional properties in response to signals sent by 
commensal and pathogenic microbe-activated cells of the innate immune system 
(Seder and Paul, 1994). Th1 and Th2 cells control intracellular microorganisms and 
helminths, respectively (Abbas et al., 1996;  Glimcher and Murphy, 2000), whereas 
Th17 cells secrete interleukin-17 (IL-17), IL-17F, and IL-22 and have significant 
roles in protecting the host from bacterial and fungal infections, particularly at 
mucosal surfaces (Ivanov et al., 2009). At appropriate concentrations of TGF-β and 
IL-6, antigen-activated CD4+ T cells upregulate RORγt and express Th17 cell 
cytokines (Zhou et al., 2008). Sayı et al. showed that Helicobacter-activated B cells 
produce high amounts of IL-6 (Sayi et al., 2011). Moreover, Helicobacter-activated 
IL-10-B cells were shown to produce IgM and IgG2b antibodies and secrete TGF-β 
(unpublished data). Based on this data, the direct effect of Helicobacter-activated IL-
10
+
B cells and Helicobacter-activated IL-10
-
TGF-β+ B cells on Th17 cell 
differentiation was investigated. 
3.5.1 IL-17 production levels of CD4
+
 T cells in co-culture with HACT-IL-10
+
 B 
cells and HACT -IL-10
-
 B cells 
The IL-17 production of CD4
+ 
T cells was examined by intracellular antibody 
staining that was detected by flow cytometry (Figure 3.10). For this purpose, the 
cells in the co-cultures were treated with Monensin (3μg/ml, Calbiochem) to keep the 
cytokines accumulated inside the Golgi complex. T cells were labeled with APC-
coupled anti-CD4 antibody. Secondly, the cells were fixed with 2% Fixation buffer 
which cross-links proteins. Next, by using the Permeabilization Buffer (Biolegend), 
67 
holes were created in the membrane thereby allowing the intracellular staining 
antibodies to enter the cell effectively. After the cells were permeabilized, FITC-
coupled anti-IL-17 antibody was used for the staining of the IL-17 that accumulated 
in the cells. 
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Figure 3.10: IL-17 Levels of CD4+ T cells co-cultured with Helicobacter-activated IL-10+B and IL-10- B cells. 
Representative flow cytometry quadrant plot (A)  and histogram plot (B) of CD4+IL-17+ T cells in co-culture 
groups compared to unstained control. Cells were labeled with anti-CD4-APC and intracellular staining was done 
for IL-17 cytokine detection. To detect the IL-17 levels for T cells, a CD4 gate was selected. (C) A graphical 
expression of the CD4+IL-17+ T cells within the co-culture groups (4 experiments). For the measurements BD 
ACCURI C6 flow cytometer and for the analyses FlowJo Software was used. Graphs were prepared with 
Graphpad Prism 6 software. Significancy evaluation was performed with Student‟s t test (p<0.05 was significant). 
C) 
A) 
B) 
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Results indicated that in both co-culture groups of CD4
+
 T cells with Helicobacter- 
activated B cell subgroups, T cells differentiated into Th17 cells. Data of four 
different experiments showed that the percentage of CD4
+
 T cells co-cultured with 
IL10
-
B cells turned into IL17 producing CD4
+
 T cells approximately 15% while with 
IL10
+
B cells the ratio was about 8% of T cells. Altogether, it could be suggested that 
in both co-culture groups there was a significant differentiation of CD4
+
 T cells into 
Th17 cells. 
3.5.2 IL-17 secretion levels of CD4+ T cells in co-culture with HACT-IL-10
+
 B 
cells and HACT -IL-10
-
 B cells 
For a better understanding of Th17 differentiation, the amounts of secreted IL-17 
levels were measured by IL-17 ELISA with the 24 hour co-culture supernatants 
(Figure 3.11). 
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Figure 3.11: IL-17 Secretion Levels in co-culture groups of CD4
+
 T cells with Helicobacter-
activated IL-10
+
B and IL-10
- 
B cells. CD4
+
 T cells were either co-cultured with 
Helicobacter-activated IL-10
+
B and IL-10
- 
B cells or left alone. Supernatants were collected 
after 24 hour co-culture and the amounts of secreted IL-17 were measured with IL-17 ELISA 
(4 independent experiments). Bar graph was prepared with GraphPad Prism 6 software. 
IL-17 ELISA results were parallel with the IL-17 intracellular cytokine staining 
analyses. Accordingly, T cells co-cultured with IL-10
+
B cells secreted more IL-17 
cytokine than only T cells (~ 1,5 fold). However, T cells that were cultured together 
with IL-10
-
B cells secreted almost 4 fold more IL-17 when compared to only T 
cells as well as almost 2,5 fold more IL-17 compared to IL-10+B and T cell co-
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culture. This would suggest that even both B cell subgroups have role in Th17 
differentiation, IL-10
-
B cells are more effective than IL-10
+
B cells in differentiating 
CD4+ T cells into Th17 cells. 
 3.5.3  Relative Ror gamma T and IL-17 expression levels of CD4+ T cells in 
co-culture with HACT-IL-10
+
 B cells and HACT -IL-10
-
 B cells 
Interleukin (IL)-17A was originally described and cloned by Rouvier et al. 
(1993) and named CTLA8, was subsequently renamed IL-17, and more recently, IL-
17A. Since it is the most significant indicator of Th17 cell presence, the gene 
expression levels of IL-17A were examined by Quantitative Polymerase Chain 
Reaction (Q-PCR). The IL-17A levels in co-culture groups were normalized to 
18sRNA results and divided to the results of only T cell groups to acquire a relative 
change in the gene expression levels (Figure 3.12). 
 
Figure 3.12: Gene expression of IL-17A in CD4
+ 
T cells co-cultured with Helicobacter-
activated IL-10
+ 
B and IL-10
-
 B cells. The average of four different experimental results was 
graphed. Only T cell groups were set as base level and the co-culture results were divided to 
only T cell results to acquire a relative change. Bar graph was prepared with GraphPad Prism 
6 software. 
Furthermore, the nuclear hormone receptor RA-related orphan receptor γt (RORγt), 
originally defined as a thymic specific isoform of RORγ (He et al., 1998), has been 
identified as the lineage-specific transcription factor for Th17 cells, required for 
their generation (Ivanov et al., 2006; and Acosta-Rodriguez  et al., 2007) (Figure 
3.13). 
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Figure 3.13: Gene expression of Ror gamma T in CD4
+
 T cells co-cultured with 
Helicobacter-activated IL-10
+ 
B and IL-10
-
 B cells. The average of four different 
experimental results was graphed. Only T cell groups were set as base level and the co-
culture results were divided to only T cell results to acquire a relative change. Bar graph was 
prepared with GraphPad Prism 6 software. 
As shown in Figure 3.12 and 3.13, IL-17A and Ror gamma T showed similar results 
for gene expression in co-culture groups. Only T cells being the basis for the 
comparison, IL-10
-
B cells induce T cells to express IL-17A and Ror gamma T almost 
1.2 fold higher than IL10
+
B cells which would explain the significant differences in 
IL-17 intracellular staining and secreted IL-17 levels in these co-culture groups 
(Figures 3.10 and 3.11). 
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4.  DISCUSSION AND CONCLUSION 
The immune response mechanisms against Helicobacter pylori involve both 
protective and damaging effects for the host. Results of many studies suggested a 
crucial role for B cells in Helicobacter infection that balances between the infection 
and T cell mediated pathology. Helicobacter induces B cells to produce and secrete 
IL-10 which is suggested to have a role in the differentiation of naïve CD4+ T cells 
into suppressive IL-10 producing Tr-1-like cells (Sayi et al.,2011); while other 
studies revealed the importance of TGF-β in both Tr-1 and Th17 differentiation (Lee 
at al., 2014; Caruso et al., 2008). 
In previous studies in our laboratory, Helicobacter-activated B cells are separated 
into two subgroups: Helicobacter-activated IL-10
+
 B cells and Helicobacter-
activated IL-10
-
 B cells. The experimental results showed that Helicobacter-activated 
IL-10
+ 
B cells are the source of the IL-10 production while Helicobacter-activated 
IL-10
-
B cells are mostly TGF-β positive (unpublished data). However, it was not 
clear if the Helicobacter-activated-IL-10
+
 B cells or the Helicobacter-activated-IL-
10
-
 B were specifically causing the Tr1 differentiation. Taking account that Bregs are 
known for producing IL-10 and TGF-β which are key cytokines in T cell 
differentiation, and focusing on these cytokines produced by Helicobacter-activated 
B cells as well as the cell-to-cell contact, in this study the role of Helicobacter-
acitvated-IL-10
+
 B cells and the Helicobacter-activated-IL-10
-
 B cells on CD4
+ 
T cell 
differentiation was investigated. 
Using magnetic isolation techniques, CD19
+
B cells and CD4
+
T cells were isolated 
from the spleens of C57BL/6 mice. The average B and T cell purities of four 
independent experiments were 90% and 93%, respectively (Figure 3.1; Figure 3.3). 
Following the B cell isolation, cells were treated with Helicobacter felis sonicate (10 
µg/ml) for 24 hours. To induce an optimal interleukin-10 (IL-10) production and 
secretion, PMA (50 ng/ml) and ionomycin (500 ng/ml) were added for the last 5 
hours of incubation. After the in vitro stimulation of B cells, IL-10 producing B cells 
were labeled and the IL-10
+
B and IL-10
-
B cells were separated. To observe the 
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interaction between the Helicobacter-activated-B cell subgroups and CD4
+ 
T cells, 
isolated CD4
+
 T cells were put on co-culture in 1:1 ratio with the Helicobacter-
activated-IL-10
+ 
B cells and Helicobacter-activated-IL-10
-
 B cells. After 24-hour 
incubation of the co-cultures of B and T cells, the cell surface markers and 
intracellular cytokine productions were examined by flow cytometry. While the 
supernatants of the co-culture groups were subjected to ELISA tests, the cell pellets 
were used for gene expression analyses. 
The intracellular staining of IL-10 of T cells co-cultured with Helicobacter-activated 
B cell subgroups resulted in significant differences when the co-culture groups were 
compared with only T cells (control group). About 15% of T cells co-cultured with 
HACT-IL-10
+
 B cells produced IL-10 while almost 20% of the T cell population was 
IL-10 positive when T cells were co-cultured with HACT-IL-10
- 
B cells (Figure 3.5). 
Altogether, it could be suggested that in both co-culture groups there was a 
significant differentiation of CD4
+
 T cells into IL10
+
CD4
+
 Tr1-like cells. In addition, 
according to IL-10 ELISA results, the co-culture groups showed twice IL-10 levels 
when compared to only T cells (Figure 3.6). For IL-10
+
B cell and T cell co-culture, a 
part of secreted IL-10 came from B cells while most of the IL-10 secreted from IL-
10
-
B cell and T cell co-culture originated from T cells. One possibility is that 
compared to IL-10
+
B cells, IL-10
-
B cells drive more IL-10 secretion from CD4
+
T 
cells. On the other hand, it could also explained by the IL-10 production of IL-10
-
B 
cells when they interact with T cells. The purities of IL-10
-
B cells would also effect 
the Tr1 differentiation since 80% pure IL-10
-
B cell population would contain 20% 
IL-10
+
B cells that would stimulate CD4
+
 T cells in the co-culture to produce IL-10 
cytokine at some levels. 
For CD25 levels, in only T cell control groups, when compared to the freshly 
isolated T cells, an increase in CD25 positive T cells was observed after 24-hour 
incubation (Figure 3.7). It could be justified by the recombinant IL-2 added into the 
culture to maintain the viability of T cells for 24 hours, since it has been reported that 
CD4
+
CD25
+
 T cells expand when they were are cultured with anti-CD3 and IL-2 
(Thornton et al., 1998).  Furthermore, the increase in CD25 expression in co-culture 
groups could be explained in two ways: the increased activation of T cells or the 
induction of T cells to differentiate into other regulatory T cell subtypes. Even 
though these results could not clarify whether the cells were just activated or 
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differentiated into a regulatory T cell subtype, the CD62L results showed the same 
pattern.  It has been known that CD62L rapidly shed from lymphocytes upon cellular 
activation (Gerberick et al., 1997). Both CD25 and CD62L levels were higher in T 
cell co-cultured with Helicobacter-activated IL-10
-
B cells (Figure 3.8). These results 
together might indicate that T cells co-cultured with Helicobacter-activated IL-10
-
B 
cells are more activated/differentiated compared to the T cells interacting with IL-
10
+
B cells. Still, the question whether the cells were activated into effector cells or 
differentiated into a suppressive, regulatory T cell subtype should be answered by 
functional analyses.  
In the literature, it has been shown that B cells, which were activated by 
Helicobacter, induce IL-10–producing CD4+CD25+ Tr1–like cells in vitro (Sayi et 
al., 2011). In addition, it has been identified that the co-expression of CD49b and 
LAG-3 distinguishes Tr1 cells from Th1, Th2 and Th17 cells (Gagliani et al., 2013). 
Flow cytometry results of CD4-CD49b-LAG3 stainings showed that almost 20% of  
T cells co-cultured with IL-10
+
B cells express CD4-CD49b-LAG3 surface markers 
while only around 10% of CD4+ T cells co-cultured with IL-10
-
B cells express 
CD49b and LAG3 together (Figure 3.9). According to those results, it could be 
suggested that CD4
+ 
T cells differentiate into Tr1-like cells when co-cultured with 
both of the Helicobacter-activated B cell subgroups; however, IL-10
+
B cells seemed 
to have more potency on CD49b-LAG3 co-expression on CD4
+
 T cell surfaces. 
Considering the CD49b-LAG3 co-expression being a regulatory cell indicator, to 
suggest that the cells expression both of the surface markers together show 
regulatory/suppressive functions, the regulatory/suppressive effects of the T cells 
need to be demonstrated on other effector cell types by in vitro suppression assays 
(CFSE dilution assay or 3H-thymidine incorporation assay). 
CD4
+
 T cells obtain distinct functional properties in response to signals sent by 
commensal and pathogenic microbe-activated cells of the innate immune system. 
Th17 cells secrete interleukin-17 and have significant roles in protecting the host 
from bacterial and fungal infections, particularly at mucosal surfaces (Ivanov et al., 
2009). At appropriate concentrations of TGF-β and IL-6, antigen-activated CD4+ T 
cells upregulate RORγt and express Th17 cell cytokines.  
As Helicobacter-activated B cells produce high amounts of IL-6 and Helicobacter-
activated IL-10
-
B cells were shown to produce and secrete TGF-β, it was 
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hypothesized that T cells co-cultured with Helicobacter-activated IL-10
-
B cells 
would differentiate into Th17. Data of four independent experiments showed that the 
approximately 15% of CD4+ T cells co-cultured with IL10
- 
B cells turned into IL-17 
producing CD4
+
 T cells while surprisingly about 8% of T cells also produced IL-17 
when co-cultured with IL10
+
B cells (Figure 3.10). One possible explanation could be 
that the purity of IL-10
+
B cells affected the IL-17 results. 80% IL-10 positive B cell 
population contains 20% IL-10 negative cells, which could have been inducing the 
IL-17 production from T cells and cause the 8% of Th17 differentiation in IL-10
+ 
B 
and T cell co-culture groups. IL-17 ELISA results were parallel with the IL-17 
intracellular cytokine staining analyses (Figure 3.11). Accordingly, T cells co-
cultured with IL-10
+ 
B cells secreted more IL-17 cytokine than only T cells (~ 1,5 
fold). However, T cells that were cultured together with IL-10
- 
B cells secreted 
almost 4 fold more IL-17 when compared to only T cells as well as almost 2,5 fold 
more IL-17 compared to IL-10
+ 
B and T cell co-culture (Figure 3.12). RORγt showed 
similar results for gene expression in co-culture groups (Figure 3.13). Only T cells 
being the basis for the comparison, IL-10
-
B cells induce T cells to express IL-17A 
and RORγt almost 1.2 fold higher than IL10+B cells which would explain the 
significant differences in IL-17 intracellular staining and secreted IL-17 levels in 
these co-culture groups. Again, the IL-17 and RORγt results could be caused by the 
IL-6 and TGF- β coming from IL-10 negative B cell population in IL-10+ B–T cell 
co-culture groups. Further experiments with higher purities in the separation of IL-10 
positive and negative groups would give a clearer picture in the Th17 response for ex 
vivo Helicobacter felis infection case.  
A schematic overview of the results obtained in this study is depicted in Figure 4.1. 
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Figure 4.1: Proposed schematic explanation of the ex vivo interaction of 
Helicobacter-activated B cells subgroups, IL10
+
 HACT B cells and IL-10
- 
HACT B 
cells, with CD4
+
T cells. 
The results of this study regarding the investigation of Helicobacter-activated B cell 
subgroup interactions with CD4
+
 T cells revealed that both Helicobacter-activated 
IL-10
+
B and IL-10
-
B cells induce IL-10 production from CD4
+
T cells and it might 
suggest that T cells differentiate into Tr1-like cells in both co-culture conditions. 
Although the CD25 and CD62L expression on T cell surfaces show significantly 
higher activation in Helicobacter-activated IL-10
-
B and T cell co-cultures, regulatory 
type indicator CD4-CD49b-LAG3 surface marker co-expressions were higher on T 
cells in the Helicobacter-activated IL-10
+
B and T cell co-cultures. In the meantime, 
intracellular cytokine analyses and relative gene expression experiments of IL-17A 
and RORγt showed significantly higher results in IL-10-B and T cell co-culture 
groups, as expected. However, interestingly IL-17 production was also observed in T 
cells co-cultured with IL-10
-
B cells. The reason behind the IL-17 and RORγt 
expressions in IL-10
+
B–T cell co-culture groups was suggested to be the IL-6 and 
TGF- β produced by IL-10 negative B cell population in the IL-10 positive co-culture 
group since these cytokines induce the Th17 differentiation.  
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Even though the whole picture is far to be clear yet and answers give rise to more 
questions, this study has contributed to the literature through providing a first step to 
show the ex vivo interactions of Helicobacter-activated B cells subgroups, IL10
+
 
HACT B cells and IL-10
- 
HACT B cells, with CD4
+
T cells. 
78 
REFERENCES 
Acosta-Rodriguez, E.V., et al., (2007), Surface phenotype and antigenic specificity 
of human interleukin 17-producing T helper memory cells. Nat Immunol 
8:639–646. CrossRefMedlineWeb of ScienceGoogle Scholar. 
Agrawal, S., et al., (2003), Cutting edge: different Toll‑like receptor agonists 
instruct dendritic cells to induce distinct Th responses via differential 
modulation of extracellular signal‑regulated kinase‑mitogenactivated protein 
kinase and c‑Fos. J. Immunol. 171, 4984–4989. 
Agrawal, A., Dillon, S., Denning, T.L., Pulendran, B., (2006), ERK1–/– mice 
exhibit Th1 cell polarization and increased susceptibility to experimental 
autoimmune ncephalomyelitis. J. Immunol. 176, 5788–5796. 
Ahmed, R., Gray, D., (1996), Immunological memory and protective immunity: 
understanding their relation. Science 272, 54–60. 
Aicher, A., Hayden-Ledbetter, M., Brady, W.A., Pezzutto, A., Richter, G., 
Magaletti, D., Buckwalter, S., Ledbetter, J.A., Clark, E.A., (2000), 
Characterization of human inducible costimulator ligand expression and 
function. J. Immunol. 164: 4689–4696. 
Alonso, A., Rahmouni, S., et al, (2002), Tyrosine phosphorylation of VHR 
phosphatase by ZAP-70. Nat Immunol. 4(1):44-8. 
Andersen-Nissen, E., Smith, K.D., Strobe, K.L., Barrett, S.L., Cookson, B.T., 
Logan, S.M., Aderem, A., (2005), Evasion of Toll-like receptor 5 by 
flagellated bacteria. Proc Natl Acad Sci USA; 102:9247-9252. 
Andreani, M., et. al., (2013), Coexpression of CD49b and LAG-3 identifies human 
and mouse T regulatory type 1 cells Nat. Med.:739-46.  
Anderton, SM.. (2006), Avoiding autoimmune disease - T cells know their limits. 
Trends Immunol 27(5):208-14. Epub 2006 Mar 30. 
Arndt, B., et al., (2011), The transmembrane adaptor protein SIT inhibits TCR-
mediated signaling. PLoS ONE 6: e23761. 
Asahi, M., Azuma, T.,  Ito, S.,  Ito, Y.,  Suto, H., Nagai, Y.,  Tsubokawa, M.,  
Tohyama, Y., Maeda, S.,  Omata, M., et al., (2000), Helicobacter pylori 
CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. 
Exp. Med. 191: 593– 602. 
Batten, M., Kljavin, N.M., Li, J., Walter, M.J., de Sauvage, F.J., Ghilardi, N., 
(2008), Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in 
murine T cells. J Immunol ;180:2752–6. 
Berthelot, J.M., Maugars, Y., (2004), Role for suppressor T cells in the 
pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts 
and hypotheses. Jt Bone Spine;71(5): 374–80. 
79 
Berthelot, J.M. et al., (2013), Regulatory B cells play a key role in immune system 
balance. Joint Bone Spine 
Beswick, E. J., Bland, D.A.,  Suarez, G., Barrera, C.A., Fan, X.,  Reyes, V.E., 
(2005), Helicobacter pylori binds to CD74 on gastric epithelial cells and 
stimulates interleukin-8 production. Infect. Immun. 73: 2736–2743. 
Beswick, E.J., Das, S., Suarez, G., Sierra, J.C.,  Graham, D.Y., Reyes, V.E.,  
(2006), Expression of B7-H1 on gastric epithelial cells: its potential role in 
regulating T cells during Helicobacter pylori infection. J. Immunol. 176: 
3000–3009. 
Beswick, E.J., Pinchuk, IV, Das, S., Powell, D.W., Reyes, V.E., (2007), 
Expression of the programmed death ligand 1, B7-H1, on gastric epithelial 
cells after Helicobacter pylori exposure promotes development of CD4+ 
CD25+ FoxP3+ regulatory T cells. Infect Immun;75:4334–41. 
Beswick, E.J., Pinchuk, IV, Earley, R.B., Schmitt, D.A., Reyes, V.E., (2011), 
Role of gastric epithelial cell-derived transforming growth factor beta in 
reduced CD4+ T cell proliferation and development of regulatory T cells 
during Helicobacter pylori infection. Infect Immun;79:2737–45. 
Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg 
DA, Ehrenstein MR, Mauri C., (2009), Selective targeting of B cells with 
agonistic anti-CD40 is an efficacious strategy for the generation of induced 
regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. 
J Immunol.,15;182(6):3492-502. 
Blaser, M.J., Crabtree, J.E., (1996), CagA and the outcome of Helicobacter pylori 
infection. Am. J. Clin. Pathol. 106: 565–567. 
Boonstra, A., et al., (2006), Macrophages and myeloid dendritic cells, but not 
plasmacytoid dendritic cells, produce IL‑10 in response to MyD88‑ and 
TRIFdependent TLR signals, and TLR‑independent signals. J. Immunol. 
177, 7551–7558. 
Bourzac, K. M., Guillemin, K.,  (2005), Helicobacter pylori-host cell interactions 
mediated by type IV secretion. Cell. Microbiol. 7: 911–919. 
Brabletz, T., Pfeuffer, I., Schorr, E., Siebelt, F., Wirth, T.,  Serfling, E., (1993), 
Transforming growth factor beta and cyclosporin A inhibit the inducible 
activity of the interleukin-2 gene in T cells through a noncanonical octamer-
binding site. Mol. Cell Biol. 13: 1155–1162. 
Broere, F., Apasov, S.G., Michail, V., Sitkovsky, M.V., Van Eden, W., (2001), T 
cell subsets and T cell-mediated immunity 
Chaouche-Drider, N., Kaparakis, M., Karrar, A., Fernandez, M.I., Carneiro, 
L.A., Viala, J., Boneca, I.G., Moran, A.P., Philpott, D.J., Ferrero, R.L., 
(2009), A commensal Helicobacter sp.of the rodent intestinal flora activates 
TLR2 and NOD1 responses in epithelial cells. PLoS One; 4:e5396. 
Chen, W., Jin, W., Hardegen, N., Lei, K., Li, L., Marinos, N., McGrady, G., 
et.al., (2003), Conversion of peripheral CD4+CD25- naive T cells to 
CD4+CD25+ regulatory T cells by TGF-beta induction of transcription 
factor Foxp3. J. Exp. Med. 198: 1875–1886. 
80 
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., Weiner, H.I., (1994), 
Regulatory T cell clones induced by oral tolerance: suppression of 
autoimmune encephalomyelitis. Science. 265:1237-1240. 
Churin, Y., L. Al-Ghoul, O. Kepp, T. F. Meyer, W. Birchmeier, and M. 
Naumann. (2003). Helicobacter pylori CagA protein targets the c-Met 
receptor and enhances the motogenic response. J. Cell Biol. 161: 249–255. 
Coghlan, J. G., Gilligan, D., Humphries, H., McKenna, D., Dooley, C., Sweeney, 
E., Keane, C., O’Morain, C., (1987), Campylobacter pylori and recurrence 
of duodenal ulcers: a 12-month follow-up study. Lancet 330: 1109–1111. 
Coombs, D., Kalergis, A.M., et al., (2002), Activated TCRs remain marked for 
internalization after dissociation from pMHC. Nature Immunology 10: 926-
31. 
Cooper, M.D., Peterson, R.D., Good, R.A., (1965), “Delineation of the thymic and 
bursal lymphoid systems in the chicken”. Nature, 205:143–146. 
Corthay, A., (2009), How do Regulatory T cells Work? Scandinavian Journal of 
Immunology. 70,326-336. 
Davidson, D., Bakinowski, M., et al., (2003), Phosphorylation-dependent regulation 
of T-cell activation by PAG/Cbp,a lipid raft-associated transmembrane 
adaptor. Mol Cell Biol. 23(6): 2017-28. 
Davis, M.M., (2002), A new trigger for T cells. Cell 110(3): 285-7. 
De Lyria, E.S., Redline, R.W.,  Blanchard. T.G., (2009), Vaccination of mice 
against H pylori induces a strong Th-17 response and immunity that is 
neutrophil dependent. Gastroenterology 136: 247–256. 
De Rosa, S.C., Herzenberg, L.A., Herzenberg, L.A., Roederer, M., (2001), 11-
color, 13-parameter flow cytometry: identification of human naive T cells 
by phenotype, function, and T-cell receptor diversity. Nat.Med.7 (2): 245–8. 
Dillon, S., et al., (2004), A Toll‑like receptor 2 ligand stimulates Th2 responses in 
vivo, via induction of extracellular signal‑regulated kinase 
mitogen‑activated protein kinase and c‑Fos in dendritic cells. J. Immunol. 
172, 4733–4743  
Duddy, M.E. et al. (2004), Distinct profiles of human B cell effector cytokines: a 
role in immune regulation? J. Immunol. 172, 3422–3427 
Duddy, M. et al. (2007), Distinct effector cytokine profiles of memory and naive 
human B cell subsets and implication in multiple sclerosis. J. Immunol. 178, 
6092–6099 
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A. et al. (2007). Novel suppressive 
function of transitional 2 B cells in experimental arthritis. J. Immunol. 
178:7868. 
Fillatreau, S., Sweenie C. H., McGeachy M. J., Anderton S. M., D. Gray, (2002), 
B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-
950. CrossRefMedline 
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Anderton, S.M., Gray, D., 
Gray, M., (2010), What are regulatory B cells? Eur J Immunol; 40: 2677–
2679. 
81 
Fiorentino, D. F., Bond, M. W., Mosmann, T. R., (1989), Two types of mouse T 
helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production 
by Th1 clones. J. Exp. Med. 170, 2081–2095  
Floess, S., Freyer, J., Siewert, C., et. al., (2007), Epigenetic control of the foxp3 
locus in regulatory T cells. PLoS Biol;5:e38. 
Fontenot, J.D., Gavin, M.A., Rudensky, A.Y. (2003), "Foxp3 programs the 
development and function of CD4+CD25+ regulatory T cells". Nat. 
Immunol. 4 (4): 330–6.  
Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., 
Rudensky, A.Y., (2005), "Regulatory T cell lineage specification by the 
forkhead transcription factor foxp3". Immunity 22 (3): 329–41.  
Gershon, R. K., (1975), A disquisition on suppressor T cells. Transplant. 
Rev.26:170. 
Gewirtz, A.T., Yu, Y., Krishna, U.S., Israel, D.A., Lyons, S.L., Peek, 
R.M.Jr.,. (2004), Helicobacter pylori flagellin evades toll-like receptor 5-
mediated innate immunity. J Infect Dis; 189:1914-1920 
Gobert A.P., et al. (2002) Cutting Edge: urease release by Helicobacter 
pylori stimulates macrophage inducible nitric oxide synthase. J 
Immunol 168: 6002–6006, 2002. 
Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J., Van Kaer, L., 
(2004), "NKT cells: what‟s in a name?". Nat. Rev. Immunol. 4 (3): 231 7. 
Gong, Q., Cheng, A.M., et. al., (2001), Disruption of T cell signaling networks and 
development by Grb2 haploid insufficiency. Nat Immunol 2(1): 29-36. 
Gough, S.C., Walker, L.S., et al., (2005), CTLA4 gene polymorphism and 
autoimmunity. Immunol Rev 204:102-15. 
Gray, M., Miles, K., Salter, D., Gray, D. and Savill, J. (2007). Apoptotic cells 
protect mice from autoimmune inflammation by the induction of regulatory 
B cells. Proc. Natl Acad. Sci. USA 104:14080. 
Groux, H.,O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J.E., 
Roncarolo. M.G., (1997), A CD4+ T-cell subset inhibits antigen-specific 
T-cell responses and prevents colitis. Nature. 389:737-742. 
Hacker, H., et al., (2006), Specificity in Toll‑like receptor signalling through 
distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207  
Hara, H., Wada, T., et al., (2003), The MAGUK family protein CARD11 is 
essential for lymphocyte activation. Immunity 18(6):763-75. 
Harris, D.P. et al. (2000) Reciprocal regulation of polarized cytokine production by 
effector B and T cells. Nat. Immunol. 1, 475–482 
Harris, P.R., Wright, S.W.,  Serrano, C., Riera, F.,  Duarte, I.,  Torres, J., Pen˜a, 
A., Rolla´n, A.,  Viviani, P., Guiraldes, E., et al., (2008), Helicobacter 
pylori gastritis in children is associated with a regulatory T-cell response. 
Gastroenterology 134: 491–499. 
Hatakeyama, M. (2004), Oncogenic mechanisms of the Helicobacter pylori CagA 
protein. Nat. Rev. Cancer 4: 688–694. 
82 
He, Y.W., Deftos, M.L., Ojala, E.W., Bevan, M.J., (1998), RORgamma t, a novel 
isoform of an orphan receptor, negatively regulates Fas ligand expression 
and IL-2 production in T cells. Immunity 9:797–806. CrossRefMedlineWeb 
of ScienceGoogle Scholar 
Higashi, H., Nakaya, A., Tsutsumi, R., Yokoyama, K., Fujii, Y., Ishikawa, S., 
Higuchi, M., Takahashi, A., Kurashima, Y., Teishikata, Y., et al., 
(2004), Helicobacter pylori CagA induces Ras-independent morphogenetic 
response through SHP-2 recruitment and activation. J. Biol. Chem. 279: 
17205–17216. 
Hirota, K., et. al., (2007), Preferential recruitment of CCR6-expressing Th17 cells 
to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. 
Exp. Med. 204, 2803–2812  
Holtmeier, W., Kabelitz, D., (2005), "Gammadelta T cells link innate and adaptive 
immune responses". Chemical immunology and allergy. Chemical 
Immunology and Allergy 86: 151–83.  
Hori, S., Nomura, T., Sakaguchi, S., (2003), "Control of regulatory T cell 
development by the transcription factor Foxp3". Science 299 (5609): 1057–
61. 
Horwitz, D. A., Zheng, S.G., Gray, J.D., (2003), The role of the combination of IL-
2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ 
and CD8+ regulatory T cell subsets. J. Leukoc. Biol.. 74: 471–478. 
Hu, X., et al., (2006), IFN‑γ suppresses IL‑10 production and synergizes with TLR2 
by regulating GSK3 and CREB/AP‑1 proteins. Immunity 24, 563–574. 
Huang, J.Q., Sridhar, S., Chen, Y., Hunt, R.H., (1998), Meta-analysis of the 
relationship between Helicobacter pylori seropositivity and gastric cancer. 
Gastroenterology 114: 1169–1179. 
Imani Fooladi AA et al., (2011), Toll-like receptors: role of inflammation and 
commensal bacteria. Inflamm Allergy Drug Targets. 2011 Jun;10(3):198-
207. 
Ishii, N., Chiba, M., Iizuka, M., Watanabe, H., Ishioka, T., Masamune, O., 
(1992), Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on 
human gastric epithelium. Gastroenterol. Jpn. 27: 23–28. 
Ivanov, II., et al. (2006), The orphan nuclear receptor RORgammat directs the 
differentiation program of proinflammatory IL-17+ T helper cells. Cell 
126:1121–1133. CrossRefMedlineWeb of ScienceGoogle Scholar 
Ivanov, II., et al., (2009), Induction of Intestinal Th17 Cells by Segmented 
Filamentous   Bacteria, Cell, Volume 139, Issue 3, Pages 485-498, ISSN 
0092-8674. 
Janeway, C.A.Jr., Travers, P., Walport, M., et. al., (2001), Immunobiology: The 
Immune System in Health and Disease. 5th edition. Glossary: Garland 
Science. 
Kabir, S., (2011), The role of interleukin-17 in the Helicobacter pylori induced 
infection and immunity. Helicobacter 16: 1–8. 
83 
Kao, J.Y., Zhang, M.,  Miller, M.J.,  Mills, J.C.,  Wang, B., Liu, M.,  Eaton, 
K.A.,  Zou, W., Berndt, B.E.,  Cole, T.S., et al., (2010), Helicobacter 
pylori immune escape is mediated by dendritic cell-induced Treg skewing 
and Th17 suppression in mice. Gastroenterology 138: 1046–1054. 
Kaku, H., Cheng, K. F., Al-Abed, Y. and Rothstein, T. L. (2014). A novel 
mechanism of B cell-mediated immune suppression through CD73 
expression and adenosine production. J. Immunol.193:5904. 
Krummey, S.M., Ford, M.L., (2014), Braking bad: novel mechanisms of CTLA4 
inhibition of T cell responses. American Journal of Transplantation 14: 
2685-2690. 
Lan, R.Y., Ansari, A.A., Lian Z., Gershwin, M.E., (2005). Regulatory T cells: 
Development, function and role in autoimmunity, Autoimmunity Reviews 4 
(2005) 351– 363. 
Langrish, C. L., et.al., (2005), IL-23 drives a pathogenic T cell population that 
induces autoimmune inflammation. J. Exp. Med. 201, 233–240  
 
Lee, B.O. et al. (2002) The biological outcome of CD40 signaling is dependent on 
the duration of CD40 ligand expression: reciprocal regulation by interleukin 
(IL)-4 and IL-12. J. Exp. Med. 196, 693–704. 
Lee, K.M, et al., (2014), TGF-b-producing regulatory B cells induce regulatory T 
cells and promote transplantation tolerance. Eur J Immunol. 44(6):1728-
1736. 
Lee, K.S., Kalantzis, A., Jackson, C.B., O’Connor, L., Murata-Kamiya, N., 
Hatakeyama, M., Judd, L.M., Giraud, A.S., Menheniott, T.R., (2012), 
Helicobacter pylori CagA triggers expression of the bactericidal lectin 
REG3g via gastric STAT3 activation. PLoS ONE 7: e30786. 
Lemaitre, B., et al., (1996), “The dorso-ventral regulatory gene cassette 
spatzle/Toll/cactus controls the potent anti- fungal response in Drosophila 
adults.” Cell, 86:973–983. 
Levings, MK, et al., (2004), Differentiation of Tr1 cells by immature dendritic cells 
requires IL-10 but not CD25+CD4+ Treg cells. Blood;1162–9. 
Lenschow, D.J., Walunas, T.L.,  Bluestone, J.A.,  (1996), CD28/B7 system of T 
cell costimulation. Annu. Rev. Immunol. 14: 233–258. 
Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K., Flavell, R.A., (2006), 
Transforming growth factor-beta regulation of immune responses. Annu. 
Rev. Immunol. . 24:99–146. 
Li, S.P., Chen, X.J., Sun, A.H., Zhao, J.,F., Yan. J., (2010), CagA+ Helicobater 
pylori induces Akt1 phosphorylation and inhibits transcription of 
p21(WAF1/ CIP1) and p27(KIP1) via PI3K/Akt1 pathway. Biomed. 
Environ. Sci. 23: 273– 278. 
Lin, J., Weiss, A., (2001), T cell receptor signaling. J Cell Sci. 114: 243-4. 
Luzza, F., Parrello, T., Monteleone, G., Sebkova, L.,  Romano, M., Zarrilli, R., 
Imeneo, M., Pallone, F., (2000), Up-regulation of IL-17 is associated with 
84 
bioactive IL-8 expression in Helicobacter pylori-infected human gastric 
mucosa. J. Immunol. 165: 5332–5337. 
Mann, M.K. et al. (2007) B cell regulation of CD4+CD25+ T regulatory cells and 
IL-10 via B7 is essential for recovery from experimental autoimmune 
encephalomyelitis. J. Immunol. 178, 3447–3456. 
Marshall, B.J., (1994), Helicobacter pylori. Am. J. Gastroenterol. 89(8, Suppl.): 
S116–S128. 
Marson, A., Kretschmer, K., Frampton, G.M., et al., (2007), Foxp3 occupancy 
and regulation key target genes during T cell stimulation. Nature; 445-931-
5. 
Mauri, C., Gray, D., Mushtaq, N., Londei, M., (2003), Prevention of arthritis by 
interleukin 10-producing B cells. J. Exp. Med. 197: 489-501. 
Mauri, C., Ehrenstein M. R., (2008), The “short” history of regulatory B cells. 
Trends Immunol. 29: 34-40. CrossRefMedline 
Mc Cracken, V.J., Martin, S.M., Lorenz, R.G., (2005), The Helicobacter felis 
model of adoptive transfer gastritis. Immunol. Res. 33:183–194. 
McGeachy, M.J. et al., (2007), TGF-beta and IL-6 drive production of IL-17 and 
IL-10 by T cells and restain T(H)-17 cell-mediated pathology, Nat. 
Immunol. 8 1390-1397. 
Mills, K.H., (2004), Regulatory T cells: friend or foe in immunity to infection? Nat 
Rev, Immunol;4(11):841– 55. 
Mitchell, P., Germain, C., Fiori, P.L., Khamri, W., Foster, G.R.,  Ghosh, S., 
Lechler, R.I., Bamford, K.B., Lombardi, G.,  (2007), Chronic exposure to 
Helicobacter pylori impairs dendritic cell function and inhibits Th1 
development. Infect. Immun. 75: 810–819. 
Mizoguchi, A. et al. (1997) Suppressive role of B cells in chronic colitis of T cell 
receptor a mutant mice. J. Exp. Med. 186, 1749–1756. 
Mizoguchi, E. et al. (2000) Regulatory role of mature B cells in a murine model of  
inflammatory bowel disease. Int. Immunol. 12, 597–605. 
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R.S., Bhan. A.K., 
(2002), Chronic intestinal inflammatory condition generates IL-10-
producing regulatory B cell subset characterized by CD1d upregulation. 
Immunity 16: 219-230. CrossRefMedline 
Mohammadi, M., Redline, R., Nedrud, J., Czinn, S., (1996), Role of the host in 
pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred 
and congenic mouse strains. Infect. Immun. 64:238–245.  
Moodley, Y., Linz, B., Yamaoka, Y., Windsor, H.M., Breurec, S., Wu, J.Y., 
Maady, A., Bernhoft, S., Thiberge, J.M., Phuanukoonnon, S., et al., 
(2009), The peopling of the Pacific from a bacterial perspective. Science; 
323:527-530. Helicobacter pylori citation 
Moore, K.W., de Waal Malefyt, R., Coffman, R.L., O’Garra, A., (2001), 
Interleukin‑10 and the interleukin‑10 receptor. Annu. Rev. Immunol. 19, 
683–765  
85 
Morris, A. and Moller, G. (1968) Regulation of cellular antibody synthesis effect of 
adoptively transferred antibody-producing spleen cells on cellular antibody 
synthesis. J. Immunol. 101, 439–445. 
Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L.M., Anderson, D.E., 
Weiner, H.L., (2009), IL-27 is a key regulator of IL-10 and IL-17 
production by human CD4+ T cells. J Immunol;183:2435–43. 
Müller, A., Oertli, M., Arnold, I.C.,  (2011), H. pylori exploits and manipulates 
innate and adaptive immune cell signaling pathways to establish persistent 
infection. Cell Commun. Signal. 9: 25. 
Nakamura, K., Kitani, A. Strober, W., (2001), Cell contact-dependent 
immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by 
cell surface-bound transforming growth factor beta. J. Exp. Med.. 194: 629–
644. 
Nakamura, K., Kitani, A., Strober, W., (2001), Cell Contact-dependent 
Immunosuppression by CD4+CD25+ Regulatory T Cells is mediated by 
Cell Surface-bound Transforming Growth Factor Beta. The Journal of 
Experimental Medicine. 629-644  
Netea, M.G., et al., (2004), Toll‑like receptor 2 suppresses immunity against 
Candida albicans through induction of IL‑10 and regulatory T cells. J. 
Immunol. 172, 3712–3718. 
Obonyo, M., Rickman, B., Guiney, D.G., (2011), Effects of myeloid differentiation 
primary response gene 88 (MyD88) activation on Helicobacter infection in 
vivo and induction of a Th17 response. Helicobacter;16:398–404.  
Ochsenbein, A.F. et al., (1999), Control of early viral and bacterial distribution and 
disease by natural antibodies, Science 2862156e2159. 
O’Garra, A., R. Chang,N. Go, R. Hastings,G.Haughton, M.Howard (1992), Ly-
1B (B-1) cells are the main source of B cell-derived interleukin 10, 
European Journal of Immunology 22 711e717. 
O’Garra, A., Vieira, P., (2004), Regulatory T cells and mechanisms of immune 
system control. Nature Med. 10, 801–805  
Okkenhaug, K., Vanhaesebroeck, B., (2003), PI3K in lymphocyte development, 
differentiation and activation. 
Okkenhaug, K., Bilancio, A., et al., (2004), Phosphoinositide 3-kinase in T cell 
activation and survival. Biochem Soc Trans. 32: 332-5. 
Parekh VV, Prasad DV, Banerjee PP, Joshi BN, Kumar A, Mishra GC (2003) B 
cells activated by lipopolysaccharide, but not by anti-Ig and anti- CD40 
antibody, induce anergy in CD81 T cells: role of TGF-beta 1. J Immunol 
2003; 170: 5897–5911. 
Parsonnet, J., Friedman, G.D., Vandersteen, D.P., Chang, Y., Vogelman, J.H., 
Orentreich, N., Sibley. R.K., (1991), Helicobacter pylori infection and the 
risk of gastric carcinoma. N. Engl. J. Med. 325: 1127–1131. 
Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A.B., Warnke, R.A.,  Jellum, E., 
Orentreich, N., Vogelman, J. H., Friedman, G.D.,  (1994), Helicobacter 
pylori infection and gastric lymphoma. N. Engl. J. Med. 330: 1267–1271. 
86 
Panchal PC, Forman JS, Blumberg DR, Wilson KT (2003) Helicobacter 
pylori infection: pathogenesis. Curr Opin Gatroenterol 19: 4–10, 2003. 
Peek, R.M., Fiske, C., Wilson, K.T. (2010). Role of Innate Immunity 
in Helicobacter pylori-Induced Gastric Malignancy. Physiological 
Reviews Jul 2010, 90 (3) 831- 858. 
Pistoia, V. (1997) Production of cytokines by human B cells in health and disease. 
Immunol. Today 18, 343–350 
Pomerantz, J.L., Denny, E.M., et. al., (2002), CARD11 mediates factor-specific 
activation of NF-kappaB by the T cell receptor complex. EMBO J 
21(19):5184-94. 
Pot, C., Jin, H., Awasthi, A., Liu, S.M., Lai, C.Y., Madan, R., et al., (2009), 
Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, 
and the costimulatory receptor ICOS that coordinately act together to 
promote differentiation of IL- 10-producing Tr1 cells. J Immunol;183:797–
801. 
Ramsdell , F., Ziegler, S.F. (2014), FOXP3 and scurfy: how it all began. Nat Rev 
Immunol. 2014 May;14(5):343-9. 
Rauws, E.A.,  Tytgat, G.N.,  (1990), Cure of duodenal ulcer associated with 
eradication of Helicobacter pylori. Lancet 335: 1233–1235. 
Read, S., Mauze, S., Asseman, C., Bean, A., Coffman, R., Powrie, F., (1998), 
CD38+ CD45RBlowCD4+ T cells: a population of T cells with immune 
regulatory activities in vitro. Eur. J. Immunol. 28:3435. 
Resende, C., Thiel, A., Machado, J. C., Ristima¨ki, A., (2011), Gastric cancer: 
basic aspects. Helicobacter 16(Suppl. 1): 38–44. 
Rolig, A.S., Carter, J.E., Ottemann, K.M., (2011), Bacterial chemotaxis modulates 
host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant 
immune response in Helicobacter pylori infection. Proc Natl Acad Sci U S 
A;108:19749–54. 
Roncarolo, M.G., Bacchetta, R., Bordignon, C., Narula, S., Levings, M.K., et al., 
(2001), Type 1 T regulatory cells. Immunol Rev;182: 68– 79. 
Roncarolo, M.G., et al., (2006), Interleukin‑10‑secreting type 1 regulatory T cells in 
rodents and humans. Immunol. Rev. 212, 28–50  
Rosser, E.C., Mauri, C. (2015), Regulatory B cells: origin, phenotype, and function. 
Immunity. 2015 Apr 21;42(4):607-12. doi: 10.1016/j.immuni.2015.04.005. 
Review. 
Saeland, S. et al. (1993) Human B cell precursors proliferate and express CD23 after 
CD40 ligation. J. Exp. Med. 178, 113–120. 
Sallusto, F., Langenkamp, A., Geginat, J., Lanzavecchia, A., (2000), "Functional 
subsets of memory T cells identified by CCR7 expression". Curr. Top. 
Microbiol. Immunol. Current Topics in Microbiology and Immunology 251: 
167–71. 
Saraiva, M., Christensen, J.R., Veldhoen, M., Murphy, T.L., Murphy, K.M., 
O’Garra, A., (2009), Interleukin-10 production by Th1 cells requires 
87 
interleukin-12-induced STAT4 transcription factor and ERK MAP kinase 
activation by high antigen dose. Immunity;31:209–19. 
Sayi, A., Kohler, E., Toller, I.M., Flavell, R.A., Muller, W., Roers, A., Muller, 
A., (2011), TLR-2-activated B cells suppress Helicobacter-induced 
preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J 
Immunol, 186:878-890. 
Schindler, C., et al., (2007), “JAK-STAT signaling: from interferons to 
cytokines.”J.Biol. Chem 282:20059-20063 
Shimoyama, A., Saeki, A., Tanimura, N., Tsutsui, H., Miyake, K., Suda, Y., et 
al., (2011), Chemical synthesis of Helicobacter pylori lipopolysaccharide 
partial structures and their selective proinflammatory responses, Chemistry–
Eur. J. 17; 14464– 14474 
Simeoni, L., Posevitz, V., et al., (2005), The transmembrane adapter protein SIT 
regulates thymic development and peripheral T-cell functions. Mol Cell 
Biol 25(17):7557-68. 
Singh, A., Carson, W.F., t.,Secor, E.R., Jr., Guernsey, L.A., Flavell, R.A., Clark, 
R.B., Thrall, R.S. et al., (2008), Regulatory role of B cells in a murine 
model of allergic airway disease. J. Immunol.  180:7318–7326. 
Singh, B., Schwartz, J.A., Sandrock, C., Bellemore, S.M., Nikoopour, E., (2013), 
Modulation of autoimmune diseases by interleukin (IL)-17 producing 
regulatory T helper (Th17) cells. Indian J Med Res. 138:591-4. 
Smith, M.F.Jr,, Mitchell, A., Li, G., Ding, S., Fitzmaurice, A.M., Ryan, K., 
Crowe, S., Goldberg, J.B., (2003), Toll-like receptor (TLR) 2 and TLR5, 
but not TLR4, are required for Helicobacter pylori-induced NF-kappa B 
activation and chemokine expression by epithelial cells. J Biol Chem; 
278:32552-32560. 
Stassen, M., Fondel. S,, Bopp, T., Richter, C., Muller, C., Kubach, J., et al., 
(2004), Human CD25+ regulatory T cells: two subsets defined by the 
integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive 
properties upon CD4+ T helper cells. Eur J Immunol; 34(5):1303–11. 
Stumhofer, J.S., Silver, J.S., Laurence, A., Porrett, P.M., Harris, T.H., Turka, 
L.A., et al., (2007), Interleukins 27 and 6 induce STAT3-mediated T cell 
production of interleukin 10. Nat Immunol;8:1363–71. 
Sun C.M. et al., (2005), Upon TLR9 signaling, CD5+B cells control the IL-12-
dependent Th1-priming capacity of neonatal DCs, Immunity 22 467e477. 
Symons, A., Beinke, S., Ley, S.C., (2006), MAP kinase kinase kinases and innate 
immunity. Trends Immunol. 27, 40–48  
88 
Takahashi, T., Y. Kuniyasu, Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., 
Shimizu, J., Sakaguchi, S., (1998), Immunologic self-tolerance maintained 
by CD25+CD4+ naturally anergic and suppressive T cells: induction of 
autoimmune disease by breaking their anergic/suppressive state. Int. 
Immunol. 10:1969. Abstract/FREE Full Text 
Takeda, K., Akira, S., (2004), Toll‑like receptor signalling. Nature Rev. Immunol. 
4, 499–511  
Takeda, K., Akira, S., (2005), “Toll-like receptors in innate immunity.” Int. 
Immunol. 17(1)1-14 
Takeda, K., Akira, S., (2009), “The roles of TLRs, RLRs and NLRs in pathogen 
recognition.” International Immunology, Vol.21, no.4, pp 317-337. 
Thornton, A.M., Shevach, E.M., (1998), CD4+CD25+ immunoregulatory T cells 
suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 
production. J. Exp. Med. 188:287. Abstract/FREE Full Text 
Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL.(2001) 
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and 
prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 
167: 1081–1089. 
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., 
Yamakido, M., Taniyama, K., Sasaki, N., Schlemper, R.J., (2001), 
Helicobacter pylori infection and the development of gastric cancer. N. 
Engl. J. Med. 345: 784–789. 
Wang, D., You, Y., et al., (2002), A requirement for CARMA1 in TCR-induced NF-
kappa B activation. Nat Immunol 3(9): 830-5. 
Wu, X., Andrews, C.P., Chen, V.W., Groves, F.D., (2009), Incidence of extranodal 
non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific 
Islanders in the United States: anatomic site and histology differences. 
Cancer Epidemiol. 33: 337–346. 
Yanaba, K. et al.(2008). A regulatory B cell subset with a unique CD1d
hi
CD5
+
 
phenotype controls T cell-dependent inflammatory responses. Immunity 
28:639. 
Yanaba, K., Bouaziz, J.D., Matsushita, T., Tsubata, T., Tedder, T.F., (2009),The 
development and function of regulatory B cells expressing IL-10 (B10 cells) 
requires antigen receptor diversity and TLR signals. J Immunol; 182: 7459–
7472. 
Yang M. et al., (2013) Regulatory B cells in autoimmune diseases. Cellular & 
Molecular Immunology 10, 122–132. 
Ye, G., Barrera, C.,  Fan, X.,  Gourley, W.K., Crowe, S.E.,  Ernst, P.B.,  Reyes, 
V.E.,  (1997), Expression of B7-1 and B7-2 costimulatory molecules by 
human gastric epithelial cells: potential role in CD4+ T cell activation 
during Helicobacter pylori infection. J. Clin. Invest. 99: 1628–1636. 
Zeng, H.M., Pan, K.F., Zhang, Y., Zhang, L., Ma, J.L., Zhou, T., et al., (2011), 
Genetic variants of toll-like receptor 2 and 5, Helicobacter pylori infection, 
89 
and risk of gastric cancer and its precursors in a chinese population, Cancer 
Epidemiol. Biomarkers Prev. 20 2594–2602 
Zhang , X., E. et al (2007) Type I interferons protect neonates from acute 
inflammation through interleukin 10-producing B cells, Journal of 
Experimental Medicine 204 (2007) 1107e1118. 
Zheng, Y., Josefowicz, S.Z., Kas, A., Chu, T.T., Gavin, M.A., Rudensky, A.Y., 
(2007), Genome-wide analysis of Foxp3 target genes in developing and 
mature regulatory T cells. Nature;445:936-40. 
  
90 
  
91 
 
 
CURRICULUM VITAE  
 
Name Surname: Güliz Tuba BARUT   
Place and Date of Birth: Berlin, 13.12.1988  
E-Mail: tuba.barut@gmail.com 
EDUCATION:  
B.Sc.: Istanbul Technical University & Montana State University, Bioengineering 
  
PROFESSIONAL EXPERIENCE AND REWARDS:  
Certificate for the use of Laboratory Animals in Research, B class ( Jan. 2014) 
PUBLICATIONS, PRESENTATIONS AND PATENTS ON THE THESIS: 
 Poster presentations: 
1) Barut, G.T., Korkmaz, A., Esencan, Z., Sayı A., (2015): Helicobacter-aktive 
B(Hakt-B) hücrelerinin CD4+ T hücreleri ile Fonksiyonel EtkileĢimleri. 23th 
National Ġmmunology Congress, 26-30 April 2015, Antalya/TURKEY. 
2) Barut, G.T., Korkmaz, A., Esencan, Z., Sayı A., (2015): Functional 
Interactions between Helicobacter-Activated B (Hact-B) cells and CD4
+
 T 
Cells. IV. International Congress of the Molecular Biology Association of 
Turkey, 27-29 November 2015, Ankara/TURKEY. 
 
